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Abstract: Nanotechnology is a rapidly evolving field, as evidenced by the large number of publications on the 
synthesis, characterization, and biological/environmental effects of new nano-sized materials. The unique, 
size-dependent properties of nanomaterials have been exploited in a diverse range of applications and in 
many examples of nano-enabled consumer products. In this account we focus on Engineered Nanomateri-
als (ENM), a class of deliberately designed and constructed nano-sized materials. Due to the large volume 
of publications, we separated the preparation and characterisation of ENM from applications and toxicity 
into two interconnected documents. Part 1 summarizes nanomaterial terminology and provides an overview 
of the best practices for their preparation, surface functionalization, and analytical characterization. Part 2 
(this issue, Pure Appl. Chem. 2018; x(x): xxx–xxx) focuses on ENM that are used in products that are expected 
to come in close contact with consumers. It reviews nanomaterials used in therapeutics, diagnostics, and 
consumer goods and summarizes current nanotoxicology challenges and the current state of nanomaterial 
regulation, providing insight on the growing public debate on whether the environmental and social costs of 
nanotechnology outweigh its potential benefits.
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1   Introduction
Nanotechnology promises to be at the forefront of many 21st century technological breakthroughs. Engineered 
nanomaterials (ENM) are a class of deliberately designed and prepared materials with nanoscale dimensions 
that have a rapidly expanding range of applications in our everyday life. The immense interest in nanotech-
nology and the new opportunities to improve the performance of traditional products that ENM present has 
led to the development of a ‘nano-particle ZOO’ [1]. Until recently, many efforts have focused on the use of 
simple ENM (e.g. metal oxides and carbon-based nanomaterials [2]) in applications such as cosmetics [3, 4], 
energy storage [5, 6], surface coatings [7], and textiles [8]. However, there is now significant interest in more 
complex nanomaterials, which already have, or are expected to find, an important role as advanced drug 
delivery systems in nanomedicine, ultra-sensitive reporters in biomedical diagnostics, and multifunctional 
probes in environmental management and in advanced electronics, transport, information and communica-
tion technology, defense, and manufacturing.
The utility of ENM can be attributed to the occurrence of unique size-dependent characteristics 
that are not exhibited by the bulk material and that lead to useful mechanical, optical, magnetic, and 
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biological properties. There are many important characteristics to consider, including size distribu-
tion, association state, shape, porosity, crystal structure, chemical composition, surface chemistry, 
charge, stability, degradation, and recycling. Unfortunately, none of these can be singled out as the 
most important for aspects related to human health. A large number of review articles have summa-
rized the unique structural features and physicochemical properties of nanomaterials that elicit their 
biological response [9–12].
Nanomaterials are now widely used in commercial products, as illustrated by an article by Vance 
et al. [13] which found that, according to the Nanotechnology Consumer Products Inventory, 1814 nano-
enabled products were available in the market (from 622 companies in 32 countries) in the year 2014 (see 
Fig. 1). Interestingly, 49 % of these products did not declare the composition of the nanomaterial they 
contained. The majority of nanomaterials used in consumer products were metallic (37 %), with 24 % of 
products containing silver nanoparticles (NP) (presumably due to their antimicrobial properties). The 
largest sector (42 %) of the market was attributed to nanomaterials used in Health and Fitness and clearly 
shows that the impact of nanomaterials on human health will be a key issue for the nanotechnology 
industry [14].
The objective of this work is to present an overview of ENM with a special focus on those where physical 
contact with consumers can be expected. Due to the complexity of the topic and the large volume of pub-
lished material, the account is divided into two separate, albeit interconnected, documents. Part 1 focuses on: 
i) the preparation of various types of ENM, ii) methods for nanomaterial functionalization, and iii) the ana-
lytical tools and methods used for the characterization of their physicochemical properties. Part 2 provides 
a detailed account of: i) nanomaterials used in therapeutics and diagnostics, ii) nanomaterials in consumer 
goods, and importantly, iii) the difficulties associated with the study of nanomaterial toxicity. This includes 
toxicological targets, pharmaco- and toxico-kinetics of nanomaterials, the four nanotoxicology principles, 
and the current state of nanomaterial regulation.
Fig. 1: Nanomaterials in commercially available products in 2014 according to the Nanotechnology Consumer Products Inven-
tory. (a) 49 % of products did not declare the composition of the nanomaterial used. (b) Of those that report the nanomaterial, 
metallic nanomaterials (particularly silver nanoparticles) were the most heavily used in commercial products (CNT  =  carbon 
nanotubes). Reproduced with permission from ref. [13].
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2   Terminology for nanomaterials
The broad applicability of nanotechnology has led to considerable variation in the terms and definitions used 
by various scientific communities and regulatory authorities [15]. Despite this, it is generally accepted that 
nanomaterials have two defining characteristics: a size on the nanoscale (typically between 1 nm to 100 nm) 
and unique size-dependent properties that are not exhibited by the bulk material. In an attempt to develop 
a common approach for describing nanomaterials, a CODATA-VAMAS working group recently released the 
second version of a Uniform Descriptor System (UDS) for Materials on the Nanoscale [16]. This project aims 
to develop a system that provides a unique description for nanomaterials and allows one to determine if two 
materials are equivalent to whatever degree is desired. Nanomaterials cannot be uniquely specified by simple 
or even complex names, since characteristics such as size, shape, and surface functionality will determine 
their properties. The UDS is being developed with extensive international consultation, including discus-
sions with the International Organization for Standardization (ISO) and American Society for Testing and 
Materials technical committees for Nanotechnology, as well as the Organization for Economic Co-operation 
and Development Working Party on Manufactured Nanomaterials. It is designed to be compatible with the 
international definition of nanomaterials from ISO technical committee 229 [17] – Nanotechnologies and the 
European Commission guidelines for regulation of consumer products containing nanomaterials [18]. ISO 
defines a nanomaterial as a material with any external dimension in the nanoscale or having internal struc-
ture or surface structure in the nanoscale; nanoscale is defined as the size range from approximately 1 nm to 
100 nm and it is noted that properties that are not extrapolations from a larger size are predominantly exhib-
ited in this size range [19]. Engineered nanomaterials are deliberately designed and prepared materials with 
nanoscale dimensions, a similar definition to manufactured nanomaterials, which are defined as “intention-
ally produced nano-sized materials for commercial purposes to have specific properties or compositions”. 
Incidental nanomaterials are generated as an unintentional by-product of a manufacturing, biotechnology, 
or other process [19].
Both the UDS and ISO TC/229 have adopted “nano-object” as the generic term to describe a material with 
one, two, or three dimensions on the nanoscale. The UDS has further sub-divided nanomaterials into 4 cat-
egories: individual nano-objects, collections of nano-objects, bulk materials that contain nano-objects, and 
bulk materials with nanoscale features. Although much initial work on nanomaterials focused on approxi-
mately spherical particles, there is now significant interest in high aspect ratio particles and one-dimensional 
materials. A wide range of terms have been used to describe these non-spherical materials. The ISO definition 
restricts the use of the term nanoparticle to a nano-object with all 3 dimensions on the nanoscale where the 
lengths of the longest and shortest axes do not differ significantly (see Fig. 2) [20]. This is similar (although 
not identical) to a definition adopted by IUPAC [21]. The term nanofibre is used for nano-objects with two 
external dimensions in the nanoscale and the third dimension significantly larger and not necessarily on the 
nanoscale; the terms nanorod, nanotube, and nanowire are recommended for solid, hollow, and electrically 
conducting nanofibres, respectively. Finally, the term nano-plate is used for nano-objects with one external 
dimension in the nanoscale and the other two external dimensions significantly larger. The various terms 
have not been employed systematically in the literature and a variety of other terms have been used. Where 
practical, we have adopted the ISO terminology for dealing with nano-objects with one, two, or three dimen-
sions in the nanoscale.
The association of individual nano-objects into clusters is frequently a limitation in preparing suspen-
sions, incorporating nanomaterials in composites, and maintaining their activity in a biological environ-
ment. Much of the literature (and ISO definitions) distinguish between the strength of the interactions that 
lead to the clustering of nano-objects, with the term agglomeration used to describe clusters that are held 
together by weak forces and that can be disrupted with modest energy input. Aggregates are considered to be 
clusters of primary particles that are held together by strong forces and are difficult or impossible to disrupt. 
These terms are generally applied to solid nanomaterials, but are problematic, as there is a continuum of 
possibilities for the strength of forces leading to the association of individual particles and because the terms 
are not applied consistently in the literature. There are a number of self-assembled nano-objects (liposomes, 
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micelles, mesoporous silica, etc.). Some are held together by non-covalent molecular interactions and are 
particularly important nanomaterials in the context of health and biomedical applications. Self-assembled 
nano-objects are typically soft materials and frequently have a highly organized structure that is dictated by 
the intermolecular interactions (π-stacking, hydrogen bonds, hydrophobic, electrostatic, hydrophilic) that 
lead to their self-assembly (e.g. assembly of phospholipid to liposomes). This is in contrast to the cluster-
ing or association of solid nano-objects, which is driven by surface interactions. It has been recommended 
that the terms aggregate and agglomerate be used interchangeably for these soft materials (see IUPAC report 
[21]). Based on the difference in terminology between various scientific communities, we believe that it may 
be necessary to distinguish between the association of solid nano-objects and nanosized self-assemblies of 
molecules. Since in most cases it is not clear which type of association is occurring for specific nano-objects, 
we avoid the use of aggregation/agglomeration here and instead use the term association.
3   Preparation of engineered nanomaterials
Two general concepts are used to produce nanomaterials: top-down and bottom-up. The top-down method 
starts with a bulk material from which particles are detached (e.g. by ablation or etching) or from which 
material is erased (e.g. lithography). The bottom-up method starts with atoms or molecules that react chemi-
cally or are self-assembled to give nanosized particles. The synthetic procedure is followed by a purification 
step, which usually employs dialysis, chromatography, centrifugation, or ultrafiltration to purify the pristine 
nanomaterial from the reagents or undesired by-products.
Key quality control factors for the synthesis of ENM include homogeneous composition, narrow size 
range, stability of the material, and high reproducibility of the method. Engineered nanomaterials with a 
wide range of compositions, sizes, and shapes are now readily available (see Figs. 1 and 3). Commercial 
materials include homopolymers, copolymers or biopolymers, self-assembled organic molecules, nanocar-
bon materials, inorganic oxides such as silica and titanium dioxide, metals, metalloids, quantum dots, and 
constructs consisting of several of these materials. The various materials are designed to exhibit properties, 
such as specific band gap energies, superparamagnetism, size-tunable emission, antibacterial activity, textile 
protection, biocompatibility, and biodegradability. Typically, the size, composition, pore size, and surface 
Fig. 2: Classification of nanomaterials. Nanostructured materials (boxes with dashed lines) are not discussed in this review. 
Adapted from ref. [22].
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functionalization of the ENM are the main factors that govern its suitability for a particular  application. In 
this section we provide a short overview of the synthetic methods that are used to synthesize common classes 
of nanomaterials. For each class of material, we also briefly describe the main applications that are likely to 
have direct impact on the human body and the specific properties that enable them. The application areas 
include biomedical uses (biosensing and diagnosis, drug delivery, imaging, cancer therapy) and consumer 
products such as cosmetics, food, and textiles.
3.1   Silica nanoparticles
Silica nanoparticles can be divided into nanoporous (less than 2 nm diameter) and mesoporous (2 to 50 nm 
diameter) categories depending on their structure. They have significant potential for medical and non-medi-
cal applications due to their large surface area, high chemical stability, biocompatibility, and straightforward 
functionalization. Example applications include filler or reinforcement for advanced composite materials 
such as dental nanocomposites, food additives (E551: silicium dioxide) in dietary products to reduce the 
fat content or as anti-caking agents, controls for texture and shelf-life of various cosmetic products, and, 
recently, new platforms for biomedical applications such as drug delivery and diagnostic testing employed 
for selecting targeted therapies [23, 24].
Synthetic methods for the production of silica NP include reverse microemulsion, flame synthesis, and 
sol-gel processing; the sol-gel process is the most widely used, since it provides control of particle size distri-
bution and morphology through the systematic monitoring of reaction parameters [25]. The sol-gel process is 
based on the hydrolysis and condensation of silicon alkoxides such as tetraethoxysilane (TEOS), commonly 
known as tetraethyl orthosilicate, in a mixed solution of water and alcohol with either an acid (e.g. HCl) or a 
base (e.g. NH3) as catalyst. In 1968, Stöber developed a reaction system that enabled the controlled growth of 
spherical silica particles of uniform size ranging from 50 to 2000 nm in diameter [26]. This initial work was 
followed by the modification of the method to prevent association and produce smaller, homogeneous, and 
uniformly sized silica NP [27–30]. It has been proven that particle size can be controlled by adjusting reaction 
parameters, such as solvent, temperature, and concentration of silicon alkoxides and ammonia. Both tem-
perature and concentration affect the rates of hydrolysis and condensation, and hence control the balance 
between the nucleation and growth processes [27]. The presence of electrolytes in the reaction medium can 
Fig. 3: Schematic illustration of different architectures of Engineered Nanomaterials.
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also assist in controlling particle size and structure. For example, the addition of small amounts of anionic 
electrolytes into the reaction mixture produced uniformly sized silica NP with diameters ranging from 20.5 to 
34.1 nm, decreasing particle size by more than 70 % [31] when compared to the medium without electrolytes. 
This occurs because electrostatic repulsion due to anions minimizes particle association and simultaneously 
inhibits particle growth.
Mesoporous silica NP have been widely explored as drug delivery systems, because their high specific 
surface area and large pore volume provide unique advantages for the encapsulation of a variety of ther-
apeutic agents [31]. The synthesis is controllable and simple to perform and is based on the formation of 
liquid-crystalline mesophases of amphiphilic molecules (surfactants) that serve as templates or structure 
directing agents around which precursors condense to form silica. Various sizes and morphologies with 
highly ordered mesoporous channels [32] can be obtained by tailoring the molar ratio of silica precursors and 
surfactants [33], manipulating pH [34], and by adding co-solvent [35]. Ultrasmall sub-10 nm silica particles 
have been synthesized using hexadecyltrimethylammonium bromide (CTAB) as a structure directing agent 
and poly(ethylene oxide) (PEO) modified silane to quench particle formation [36]. CTAB acts as a template 
to generate silica particles with a single pore size and the introduction of PEO generates a modified surface 
that is suitable for biomedical applications. The same group have since advanced their method of generating 
ultrasmall silica NP by employing water as a solvent [37].
3.2   Titanium dioxide nanoparticles
Nano-sized titanium dioxide (TiO2) is used across a wide range of applications, such as paint pigments, 
glazes, enamels, plastics, paper, fibers, foods, pharmaceuticals, cosmetics, toothpastes, antimicrobial appli-
cations, and catalysts for air and water purification or for energy storage [38]. However, nanoscale TiO2 is 
predominantly used in personal care products, such as topical sunscreens that block ultraviolet radiation 
and other skin care products [39]. TiO2 NP have a greater protective ability than micron sized particles and 
provide a more transparent product with less residue. Other applications of TiO2 would also benefit from 
smaller primary particle sizes. Therefore, the amount of nanoscale TiO2 used in consumer goods is expected 
to increase significantly. Food-grade TiO2 has also been shown to contain up to 35 % primary particles that 
are less than 100 nm in diameter [40].
The sol-gel method used to make silica NP can also be applied to TiO2 NP synthesis. The reaction involves 
the hydrolysis of a titanium precursor, usually titanium alkoxides [41] or titanium halides [42], followed by 
condensation. Different particle sizes and shapes can be obtained by varying reaction parameters, such as 
concentration, pH, pore size, and temperature [43]. Surface stabilizers are used to form an insulating organic 
layer on the surface, preventing particle association. Although sol-gel processes usually result in amorphous 
materials, different methods have been reported to improve the crystallinity of TiO2 NP, including calcination 
[44], ultrasound irradiation [45], and the addition of a base [46], or of salts and acids [47].
Micelles[48] and reverse micelles [49, 50] are also employed for the synthesis of TiO2 NP. Restricting the 
reaction to the interior of micelles or reverse micelles provides control of particle size in either aqueous or 
non-aqueous solution. The ratio of titanium precursor, surfactant, and water; the ammonia concentration; 
and the reaction temperature are all significant in controlling particle size and size distribution. TiO2 particles 
synthesized via this method have an amorphous structure. In order to increase crystallinity while avoiding 
association, further annealing in the presence of micelles at temperatures considerably lower than those 
required for the traditional calcination treatment [51] can be applied.
Other popular synthetic approaches include hydrothermal and solvo-thermal methods, which are almost 
identical except for the use of water and organic solvents, respectively. These methods are normally con-
ducted under high pressure in autoclaves made of steel with PTFE liners, enabling the use of temperatures 
above the boiling point of a given solvent. Usually, the solvo-thermal method yields better control of size, size 
distribution, and crystallinity of TiO2 NP than that achieved with the hydrothermal method, due to the higher 
boiling point of some organic solvents [44].
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3.3   Iron oxide nanoparticles
Iron oxide nanoparticles are the most commonly employed magnetic nanoparticles (MNP). Engineered with 
a hydrophilic surface coating, they have demonstrated great promise in the biomedical field. Aside from their 
unique magnetic properties, injectability and high accumulation in the target tissue or organ make them suit-
able for diagnostic and therapeutic applications, such as magnetic resonance imaging (MRI) contrast agents 
[52], targeted drug delivery [53], and magnetic field assisted radionuclide therapy [54].
Various methods have been developed to synthesize uniform iron oxide-based MNP with homogene-
ous composition and narrow size distribution [55]; these include microemulsions [56], sol-gel synthesis [57], 
sonochemical reaction [58], hydrothermal reaction [59], thermal decomposition [60], and electrospray syn-
thesis [61]. However, the co-precipitation technique is probably the simplest and most efficient method [55]. 
Fe3O4 particles can be synthesized via co-precipitation of iron(II) and iron(III) ions in aqueous solution [62]. 
Although large amounts of NP can be synthesized in this way, the control of particle size distribution remains 
a challenge and the nucleation and growth steps must be separated, as explained by LaMer’s theory, in order 
to produce uniform NP [63]. This can be achieved by burst nucleation with hot injection of reagents into the 
reaction system, which leads to faster nucleation and a concomitant decrease in particle size. Surfactants are 
necessary to coat the particle surface and prevent the association of smaller particles.
Thermal decomposition is another important method and is now routinely used to prepare iron oxide-
based MNP with controlled size and morphology [64]. Metal precursors, usually organometallic complexes, 
undergo decomposition at high temperature in an organic solvent with surfactant added for NP stabilization 
and size control. For example, uniform MNP of 20  nm in diameter are synthesized by the decomposition 
of iron(III) acetylacetonate, Fe(acac)3 at high-temperature (265 °C), in phenyl ether and in the presence of 
alcohol, with oleic acid and oleylamine as surfactants [65]. FeNP with sizes ranging from 5 to 19 nm can be 
produced via a similar method by the decomposition of iron(0) pentacarbonyl [Fe(CO)5] in dioctyl ether with 
oleic acid and oleylamine [66]. Further controlled oxidation transforms them to uniform γ-Fe2O3 NP. The size 
and morphology of NP can be controlled by varying the reaction conditions, including time, temperature, 
concentration, and ratios of reactants. This method can be extended to alloy particles, such as CoFe and 
CoFe2O4, by simultaneous decomposition of Fe(CO)5 and Co2(CO)8 in 1,2-dichlorobenzene [67], or Fe(acac)3 
and Co(acac)2 in hexadecane-1,2-diol [68].
Iron-based MNP can be synthesized through the reduction of metal salts in the presence of surfactant, 
which prevents particle association [69]. A wide range of common reducing agents, including hydrazine [70], 
sodium borohydride [71], lithium borohydride [72], and polyols [73], can be used for metal salt reduction. The 
synthesis of CoFeNP is also achieved by the simultaneous co-reduction of iron(II) sulfate and cobalt chloride 
salts with sodium borohydride [74]. By using potassium borohydride, hollow CoFe is produced [75]. Reactions 
carried out in polyols, such as ethylene glycol or propane-1,2-diol, tend to yield more uniform products. Such 
polyols effectively act as bidentate chelating agents for the solvated metal cations and, in some cases, also 
serve as reducing and/or stabilizing agents for the metal nanoparticles [76].
3.4   Gold nanoparticles
Gold nanomaterials with novel properties, biocompatibility, and relatively low toxicity, have attracted 
considerable interest in applications such as diagnostics and therapeutics [77]. More recently, their use 
in cosmetics and toiletries as anti-wrinkling agents to inhibit the formation of advanced glycation end 
products has also been explored. Gold nanomaterials can now be divided into two distinct categories: gold 
nanoparticles (Au NP) and gold nanoclusters. The most interesting property of gold nanoparticles is their 
tunable surface plasmon resonance, which induces a dramatic enhancement in their absorption and scat-
tering. The surface plasmon band is tunable from the UV to the NIR region by changing the particle size 
(1 to 100 nm length scale) and shape [78]. Although the term nanoparticle defines an object with all three 
dimensions below 100 nm, such as spheres, cubes or prisms, the term gold nanoparticle is widely used in 
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the literature to describe most gold nano-objects, independent of whether they fit this definition (e.g. gold 
rods, plates).
Gold nanoclusters are usually smaller than 3 nm, composed of several to roughly one hundred atoms, 
and are characterized by the strong quantum confinement effect of free electrons in the particles. Recent 
synthetic advances enabled the preparation of water-soluble gold nanoclusters with tunable size or emission 
colors, which accelerated their use as novel labels in biosensing and bioimaging [79].
Significant effort has been devoted to the synthesis of gold nanoparticles, focusing on control over 
size, shape, solubility, stability, and functionality [80]. Developed by Turkevich et al. [81] in 1951, the citrate 
reduction of HAuCl4 is still one of the most commonly used synthetic methods for Au NP production. In this 
method, [AuCl4]− is reduced by sodium citrate, which acts as both reducing agent and stabilizer, in boiling 
water. Particles with sizes ranging from 12 to 150 nm can be obtained by varying the nucleation rate and 
through changing the sodium citrate concentration.
Another breakthrough in gold nanoparticle synthesis is the Brust-Schiffrin method. In this method, 
[AuCl4]− is transferred from an aqueous phase to toluene using tetraoctylammonium bromide as the phase-
transfer reagent and reduced with aqueous sodium borohydride in the presence of dodecanethiol. The 
nanoparticles synthesized are covered with strongly bound thiol-ligands which prevent association. Gold 
nanoparticles with sizes ranging from 1.5 to 5.2 nm were obtained by adjusting reaction conditions, including 
the gold to dodecanethiol ratio, temperature, and the reduction rate [82].
A water-based synthetic method is often preferred over the two-phase method, since it uses less toxic 
solvents and the NP are hydrophilic, and thus more biocompatible. Functional block polymers can also be 
introduced into the system, where they simultaneously serve as reductants, structure-directing agents, and 
colloidal stabilizers. For example, in a one-step synthesis of Au NP with an average diameter of about 10 nm, 
the (PEO-PPO-PEO) block copolymers act as efficient reductants and stabilizers. The reaction takes place in 
air-saturated aqueous solution at room temperature, and no other reducing agents are needed [83]. When 
water and commercially available polymers are used, this synthetic method is environmentally benign and 
economical.
3.5   Silver nanoparticles
Silver has many attractive characteristics that make it applicable to a number of fields, including opto-
electronics, catalysis, chemical/biological sensing, in vivo imaging, and medicine [84]. Silver nanoparticles 
(Ag NP) have proven to be particularly attractive as antibacterial agents [85] and are regularly incorporated 
into apparel to prevent the formation of odour-causing bacteria [86]. They provide an excellent platform for 
Surface Enhanced Raman Spectroscopy detection and enable single molecule detection. The utility of Ag NP 
in a variety of applications has led to the investigation of different approaches for nanoparticle preparation 
using chemical and physical approaches.
Chemical reduction is the most common approach for the production of Ag NP and typically involves 
three components: (i) metal precursor, (ii) reducing agents, and (iii) stabilizers/capping agents. The most 
common metallic precursors are silver nitrate, silver acetate, silver citrate, and silver chlorate, while the most 
frequently used reducers are sodium borohydride and sodium citrate. The main drawback of chemical syn-
thesis is the inability to produce NP of well-defined shape and size. For example, the Creighton method is 
limited to producing Ag NP of around 10 nm. The Lee-Meisel method, which employs AgNO3 in a variation 
on the Turkevich method used for Au NP synthesis, produces 30 to 150 nm NP with various morphologies 
(spheres, polyhedrons, plates) [87]. Reproducible Ag NP synthesis can be related to the initially formed nuclei 
that can develop into different crystal sizes and morphologies, which are dependent on reaction conditions 
[88]. Indeed, it has been highlighted that even small impurities in silver nitrate can influence the shape and 
crystal structure of the resultant NP, as reviewed by Xia [89]. The association of Ag NP is typically prevented 
through the introduction of stabilizing agents, such as poly(N-vinylpyrrolidone), on the particle surface. 
Bastus﻿́ et al. reported the controlled synthesis of highly uniform citrate-stabilized Ag NP by reducing AgNO3 
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using a combination of sodium citrate and tannic acid [87]. Small, uniform Ag NP (10 to 20 nm) could be 
produced by varying the molar ratio of tannic acid to sodium citrate (0.005:1 up to 1:1). Particles of defined 
size (e.g. 15 nm) were then used as ‘seeds’ for the subsequent production of larger uniform NP by sequentially 
adding more sodium citrate, tannic and AgNO3 in a defined ratio. The new generation of well-defined larger 
NP was then used as new ‘seeds’ to create even larger NP with a narrow size distribution. Overall, the authors 
reported the ability to produce citrate-stabilized Ag NP over a range of 10 to 200 nm with standard deviation 
less than 10 %.
Prominent physical methods of Ag NP production are laser ablation and evaporation/condensation. 
Laser ablation involves the use of a silver plate immersed in a liquid phase. A focused, high-energy laser 
irradiates the metal to generate a heated plasma containing a high concentration of silver atoms and ions 
that cool in the solvent, facilitating Ag NP growth [90, 91]. A number of factors govern the size, shape, growth 
rate, and uniformity of the resultant NP. These factors include the laser wavelength, pulse duration (femto-, 
pico- or nanosecond regime), laser fluence, ablation time, and the solvent properties [92]. Another physical 
preparative method is the evaporation/condensation technique, which uses a tube furnace. One advantage 
of physical synthesis methods is that they do not require chemical reagents and can therefore generate high 
purity colloids.
Alternative ‘green synthesis’ methods of generating Ag NP are becoming increasingly popular. Green 
synthesis uses biological sources, such as bacteria [93], fungi [94] and plants [95], which have naturally 
occurring biocompatible reducing agents and stabilizers for NP generation. These methods circumvent the 
need to use potentially harsh chemical agents and aim to minimize the environmental impact of NP produc-
tion. However, the scalability of such approaches remains unresolved. A recent example of this was demon-
strated by Giessen and Silver when they engineered 25 nm diameter encapsulins from Thermotoga maritima 
to produce 13.5 nm Ag NP. Encapsulins are a new class of microbial nanocompartments and were exploited to 
confine particle growth [93]. This was enabled by genetically modifying the encapsulin to display the silver-
binding AG4 peptide, first reported by Naik et al. [96], on their compartmental interior. The authors high-
lighted that the exact mechanism of silver precipitation by AG4 remains to be fully elucidated. However, 
the hydroxyl groups of tyrosine residues have been shown to be active in silver ion reduction [97] and NMR 
studies of |AG4 by Lee et al. [98] reported shifts in the hydrophobic side chains of leucine, phenylanaline, and 
arginine during Ag NP formation, indicating that they may serve as NP formation sites.
3.6   Quantum dots (QD)
Quantum dots (QD) are nanoscale semiconductor crystals that are generally composed of elements from 
groups 2–4, 3–5, or 4–6 and have sizes ranging from 2 to 10 nm [99, 100]. They have size dependent optical 
properties that are due to quantum confinement effects on electronic states. QD have unique advantages 
over traditional fluorescent dyes, including a broad excitation range, narrow and size-tunable emission, high 
luminescence yields, and good photochemical stability [101], making them appealing in vivo and in vitro fluo-
rophores in biological applications [102].
Since Brus et al. first reported colloidal QD in 1983 [103], researchers have been developing synthetic 
methods for these nanomaterials. The current methods can be divided into two classes: organometallic syn-
thesis based on high-temperature thermolysis and aqueous synthesis with thiols as stabilizers [100]. In 1993, 
Bawendi et al. reported a simple route for the synthesis of high-quality near-uniform 2–6 QD by injecting orga-
nometallic reagents, such as dimethylcadmium, into hot coordinating solvent, which provided temporally 
discrete nucleation, as well as the controlled growth of macroscopic quantities of QD with sizes from about 
1.2 nm to about 11.5 nm [104]. This method was later optimized to a one-pot synthesis by using cadmium oxide 
as the precursor instead of dimethylcadmium, which is difficult to handle and unstable [105]. Core-shell QD, 
in which the higher-band-gap shell protects the inner core from oxidation and improves the photolumines-
cence quantum yields, provides materials with novel properties that are more attractive for applications [106]. 
Examples of core-shell QD include CdS/CdSe [107], CdS/ZnS [108], and CdSe/ZnS [106, 109]. In the synthesis 
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of CdSe/ZnS QD, uniform CdSe quantum dots are first synthesized through pyrolysis of Cd and Se precursors 
and then injected into a solution of trioctylphosphine oxide to which Zn and S precursors are added dropwise 
under a N2 atmosphere to form a ZnS layer. When prepared in organic solvent, the poor aqueous dispersibil-
ity resulting from hydrophobic surface ligands makes QD unsuitable for biomedical applications. Therefore, 
ligand exchange with hydrophilic molecules and polymers or silica coatings is necessary, as discussed below.
Compared to thermolysis in organic solvents, aqueous methods are preferable, since they are cheaper 
and more reproducible, use less toxic materials, and produce biocompatible QD with high aqueous stability 
and biocompatibility [110]. This makes them more promising for biomedical use [111], even though they have 
lower photoluminescence quantum yields and therefore significant effort has been directed towards aqueous 
synthesis methods [110]. In the synthesis of CdTe, cadmium perchlorate is dissolved in water in the presence 
of NaHTe followed by addition of a thiol stabilizer such as 2-sulfanylethanol [112], 2-sulfanylacetic acid [113] 
or cysteine [114], which are soluble or miscible in water at appropriate pH. CdTe nanocrystals with excellent 
aqueous dispersibility are produced after refluxing under aerated conditions [115]. By taking advantage of 
high temperature hydrothermal synthesis techniques, the photoluminescence quantum yield and size dis-
tribution of CdTe QD are significantly improved [110]. In order to modify this time-consuming procedure, 
microwave radiation is often introduced [116]. Studies have shown that microwave assisted aqueous synthe-
sis is generally faster, simpler, and more energy efficient compared to conventional hydrothermal synthesis 
[117, 118]. It is believed that fast and uniform heating from microwave radiation results in good crystallinity 
and high quality QD.
3.7   Polymeric nanoparticles
Polymeric materials have been used in a range of pharmaceutical and biotechnology products for more 
than 70  years. Polymer-based multifunctional nanoparticles capable of targeting, diagnosis, and drug 
delivery were developed more recently [119]. Polymeric NP can be loaded or coated with drugs and can 
be used to administer, carry, and deliver drugs [120]. Ever since Langer and Folkman reported sustained 
release of biochemically active macromolecules from biodegradable polymers in 1976 [121], polymer-based 
NP have impacted virtually every branch of medicine [122]. Today, the most commonly used polymers for 
drug release applications include poly(D,L-lactic acid)-co-(glycolic acid) (PLAGA), poly(lactic acid) (PLA) 
and poly(glutamic acid) (PGA), due to their favorable bioavailability, biocompatibility, biodegradability, 
and low toxicity [123]. Some polymer-based NP have received regulatory approval as drug delivery systems 
in humans [124, 125].
A number of bottom-up and top-down methods are available for the preparation of polymeric NP. The 
bottom-up techniques – emulsion, interfacial and precipitation polymerization – employ a monomer as the 
starting point [126]. The top-down techniques include solvent emulsion evaporation [127–130], solvent dis-
placement [131, 132], and salting out methods [133, 134] and start with a polymer that is preferably bio-resorb-
able and ideally bio-degradable in vivo [135]. The presence of surfactant is essential to prevent nanoparticle 
association and ensure the stability of nanodispersions. Solvent emulsion evaporation is the most common 
technique and requires the emulsification of the polymer solution as the first step, followed by homogeniza-
tion of the resulting mixture [136]. The emulsification method can be divided into two categories, oil-in-water 
(O/W) emulsification (single emulsion), and water-in-oil-in-water emulsification, W/O/W (double emulsion). 
The O/W emulsification technique is suitable for entrapping hydrophobic drugs, while W/O/W is generally 
used for the encapsulation of hydrophilic drugs and proteins [128, 137]. The size of polymeric NP can be con-
trolled by adjusting reaction parameters, such as stirring rate, temperature, and the type and concentration 
of dispersing agent [138].
Solvent displacement, also called nanoprecipitation [132], involves the use of an organic solvent that is 
miscible with an aqueous phase in the presence or absence of surfactant [131, 139–141]. Polymers and drugs are 
dissolved in the organic solvent and are transferred to an aqueous solution, where the hydrophobic polymers 
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and drug self-assemble into core-shell nanospheres that precipitate [142]. This technique is  amenable to 
scale-up to an industrial scale and requires only gentle stirring with no high shear stress [126].
Non-degradable polymers, such as polystyrene, also play an important role in this field. In medicine, 
polystyrene microspheres have been used in the treatment of hepatocellular carcinoma, based on the 
principle that the vascular bed of many solid tumors is hyperpermeable to macromolecules and nano-
particles, allowing their accumulation in tumors [143]. The synthesis of polystyrene particles is typically 
accomplished by bottom-up polymerization, although this method cannot independently control particle 
size and molecular weight [144]. Top-down techniques such as nanoprecipitation were also employed 
[145, 146].
“Intelligent” nanoparticles composed of stimulus-responsive polymers, for example pH-responsive 
polymers (e.g. poly(acrylic acid)) and thermal-responsive polymers (e.g. poly(N-isopropylacrylamide)), have 
been extensively studied. When subjected to external signals they produce physical or chemical changes 
that include variations of macromolecular structures, solubility, surface properties, swelling, and dissocia-
tion [147]. Most stimulus responsive polymers are synthesized via bottom-up techniques. Conjugated poly-
mers also show potential for biomedical applications. For example, cyanovinylene–backbone conjugated 
polymers can be used as in vivo nanoprobes due to their high chromophore density and high fluorescence 
efficiency [148]. The nanoparticle synthesis method is quite similar. In this case, hydrophobic monomers are 
dissolved in a neat liquid surfactant and then micellized in water, allowing polymerization to occur in the 
nanoscopic non-polar interior of the micelles.
3.8   Carbon nanotubes
Carbon nanotubes (CNT) are hollow nanofibers (see Fig. 2) whose walls are composed of sheets of graphene 
that exhibit a hexagonal arrangement of sp2-hybridized carbon atoms and were first observed and described 
by Radushkevich and Lukyanovich in 1952 [149]. Their unique structures result in impressive mechanical, 
thermal, magnetic, optical, electrical, surface, and chemical properties that have potential for extensive 
biomedical applications in areas such as in vivo imaging, biosensing, and drug delivery [150, 151]. CNT are 
divided into two basic forms, single walled carbon nanotubes (SWCNT) consisting of a single tube of gra-
phene, and multiwalled carbon nanotubes (MWCNT) composed of several concentric tubes of graphene.
Arc discharge, laser ablation, and chemical vapor deposition are the three main production methods for 
CNT. The simplest method to achieve large-scale synthesis applies a DC arc discharge between two graph-
ite electrodes in the presence of a metal catalyst at low pressure in a controlled atmosphere composed of 
inert/or reactant gas [152]. The catalyst used and the type and pressure of the gas affect the CNT morphol-
ogy, purity, and yield. Researchers concluded that arc discharge in an organic atmosphere produced more 
MWCNT because organics could be ionized and decomposed into hydrogen and carbon atoms, which con-
tribute to MWCNT synthesis.
Laser ablation, another synthetic method for CNT first demonstrated in 1995 [153], favors the growth of 
SWCNT with controlled diameter depending on reaction temperature. The principles and mechanisms are 
similar to arc discharge with the difference that the energy is provided by a laser beam focused onto a metal-
graphite composite target, which is placed in a high-temperature furnace. A number of factors including laser 
intensity, furnace temperature and metal catalyst affect the size, morphology, yield, and physical character-
istics of SWCNT [154].
Chemical vapor deposition is now the standard method for synthesis of CNT. It is not only controllable, 
but also economically viable for large scale CNT production [155]. This method involves decomposition of 
various hydrocarbons over a transition metal supported catalyst, which can be carried out at atmospheric 
pressure [152] in a temperature range of 300 to 1200 °C [156]. A variety of gaseous and liquid hydrocarbon 
feedstocks can be used as precursors. Besides transition metals and rare earth elements, catalysts formed 
from metals combined with natural minerals, such as forsterite, diopside, quartz, and magnesite, have also 
been used [157].
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3.9   Liposomes
Although liposomes are not typically considered to be a class of ENM, they are often functionalized to have 
novel properties for biomedical applications. Liposomes have significant potential for drug delivery and cur-
rently represent the majority of the clinically approved nano-enabled therapeutics. Drug delivery applica-
tions typically require the functionalization of the liposomes to improve stability and incorporate targeting 
moieties. Liposomes came to prominence in 1965 following work by Bangham [158] in which the amphiphilic 
nature of their structure was revealed through the identification of the phospholipid bilayer. They are used 
to carry hydrophilic drugs in their interior and hydrophobic drugs inside the membrane, which has led to 
liposomes becoming the most widely studied drug delivery nanomaterial for cancer treatment.
Several techniques, such as Bangham’s method, detergent-depletion, reverse phase evaporation, ether/
ethanol injection and emulsion methods, as well as alternative methods including dense gas and supercriti-
cal fluid techniques have been reported and reviewed elsewhere [159, 160]. Due to the differences in prepa-
ration methods and lipid compositions, liposomes can be classified according to their lamellarity (uni- and 
multilamellar vesicles), size (small [diameter below 100 nm], intermediate [100 to 250 nm], or large [above 
250 nm]), and surface charge (anionic, cationic, or neutral). The ‘First generation’ liposomes used for drug 
delivery suffered from problems, such as rapid accumulation in mononuclear phagocyte system organs (e.g. 
liver and spleen). Their circulation half-life has been dramatically improved by grafting biocompatible poly-
mers, such as polyethylene oxide, to the liposome surface. This class of liposome has since been dubbed 
‘stealth liposomes’ [161]. In the case of the commercially available stealth liposome Doxil®, a liposome plat-
form encapsulating the chemotherapy drug doxorubicin, a circulation half-life 100 times that of free doxo-
rubicin is observed [162]. Doxil® has also been shown to lower cardiotoxicity 7-fold in comparison to free 
doxorubicin. Liposomes are widely available commercially, with global sales in the hundreds of millions of 
dollars annually. Doxil® and Myocet® encapsulate the chemotherapy drug doxorubicin, with the latter being 
a non-PEGylated liposomal system. AmBisome® is a liposomal formulation of the broad-spectrum polyene 
antifungal agent amphotericin B [163].
3.10   Bioinspired nanomaterials
Biomacromolecules are typically nanosized, more or less bio-tolerable, and intrinsically biodegradable, 
provided suitable enzymes are present and the macromolecules have not been chemically modified. These 
properties make them attractive starting points for producing engineered nanomaterials for biomedical appli-
cations. Proteins, such as serum albumin and ferritin, and nucleic acids are among the more commonly used 
biomacromolecules in NP synthesis. Serum albumin, the predominant protein in blood, has binding sites for 
amphiphilic molecules and can be cross-linked, for example using glutaraldehyde, to form nanoparticles. 
Cross-linking in the presence of a drug generates a nanoparticle that can be used for slow drug release [164]. 
However, excessive use of glutaraldehyde as the cross-linker can inhibit the degradability of the nanomate-
rial and, as the particle degrades, the released glutaraldehyde may cause undesirable interactions with other 
molecules in the body. Ferritin is an 8-nm diameter iron-storage protein that consists of 24 identical subunits 
that form a cavity containing approximately 4000 iron(III) atoms. The high iron content makes ferritin a 
useful contrast agent for imaging techniques [165]. In addition, disassembly of the protein scaffold provides 
a source of iron nanoparticles and its reassembly in the presence of a drug provides a novel drug delivery 
system. In a third example, viral structural proteins can self-assemble in vitro to give virus-like particles that 
lack genetic material. Incorporation of antigens provides a powerful vaccine and virus-like particles can also 
be used to encapsulate drugs [166]. Similarly, encapsulins, which are spherical bacterial organelles with a 
diameter of about 30 nm, have been used to engineer nanosized materials.
DNA nanostructures can be engineered by programmable self-assembly to give well-defined architec-
tures (DNA origami). These nanostructures can be equipped with functional groups at preselected sites 
and are promising substrates for vaccination, drug delivery, and other applications [167]. Similarly, RNA 
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nanoparticles can be assembled from suitable precursor RNA strands [168]. When engineered from RNA 
strands that influence gene-expression (interference RNA) or carry catalytic activity (catalytic NA), they are a 
promising approach for various biotechnology applications. Moreover, carbohydrates of various chain length 
and composition (e.g. dextran, chitosan) have been used either with or without further modification as the 
basis for ENM. Carbohydrate-based nanoparticles have been highlighted for their medical applications for 
diagnostics and therapy, molecular imaging, and drug delivery, particularly in cancer chemotherapy.
4   Surface functionalization of nanomaterials
Most nanomaterials require modification or functionalization, either during the initial synthesis or for post-
synthesis applications (see Fig. 4). In some cases, modifications are necessary to improve the stability of the 
nanomaterial (towards dissolution or association), to change its hydrophobicity or hydrophilicity for disper-
sion in appropriate solvents, or to enhance biocompatibility. In other cases, surface functionalization may 
protect or improve the performance of the core material or reduce the overall cost of the material. Water-
soluble functional nanomaterials are indispensable for various biomedical applications, but most of the good 
synthetic methods for noble metals, quantum dots, and magnetic metal oxides produce nanomaterials with 
a hydrophobic surface [78]. Therefore, water solubilization and functionalization to convert hydrophobic NP 
into hydrophilic ones and the introduction of additional chemical functionality are key steps for applications 
[169]. Different strategies have been used to functionalize nanoparticles with a variety of ligands, such as 
small molecules, surfactants, polymers, and biomolecules [170]. For therapeutic applications, it is common 
to introduce a polymer coating that is biocompatible (for example PEO, known by its trivial name PEG) and 
also to include targeting moieties. These include a variety of bio-recognition elements, such as antibodies, 
nucleic acids, peptides, and ligands for specific receptors. In many cases, the functionalization of the nano-
material can be used to produce a multifunctional platform that incorporates both drug delivery and diag-
nostic imaging capabilities. The procedures used for surface modification and stabilization include many 
chemicals, some of which can have a significant effect on NP properties. Precise information is required 
on the qualitative and quantitative presence of the ligands and stabilizing moieties attached to the surface, 
Fig. 4: Surface-modifications of ENM. Adapted from ‘Coatings for nanomaterials’, ref [171].
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as well as residual reagents that may not have been removed during purification. In the case of targeting 
ligands, it is particularly important to control their surface orientation and verify that they retain their native 
binding affinity for the receptor of interest.
Here we review five of the most common strategies for nanomaterial functionalization: silica coating, 
ligand exchange, polymer coating, surface modification of carbon nanotubes, and bioconjugation to intro-
duce targeting moieties. The general challenges and approaches used for surface modification and function-
alization are summarized in several recent reviews [172–179].
4.1   Silica coatings
The introduction of a silica coating is one of the most widely used methods for the surface functionalization 
of NP [180, 181]. Silica serves as a robust layer that prevents the degradation of optical properties, imparts 
water solubility, and protects the core NP from the external environment [182, 183]. Classic silica coating 
methods include the use of silane coupling agents [184], the Stöber method [185, 186], and reverse micro-
emulsion [187]. Silica coatings can be grafted on most types of nanomaterials that have a chemical or elec-
trostatic affinity for silica. Silica coating is usually formed as a one to tens of nanometer-thick porous silica 
shell on the surface of the nanomaterial core [188]. This process is frequently referred to as silanization in the 
literature [189–191].
The concept of silane coupling agents was reported by Plueddemann and his coworkers in 1962 [184]. 
Since then researchers have developed silane coupling agents with different functional groups for NP surface 
modification. As examples, (3-methacryloxy)propyl]trimethoxysilane [192], (3-aminopropy)ltriethoxysilane 
(APTES) [193], (3-isocyanatopropy)ltrimethoxysilane [194] and 3-(trimethoxysilyl)propyl methacrylate [195] 
have been used to functionalize nanoparticles with surface hydroxyl groups, such as silica, TiO2, and Fe3O4 
NP. The methoxy/ethoxy groups of these silanes condense on the NP surface, forming a silica layer around 
the particle. As a result, functional groups are imparted on to the NP surface and are available for future 
reactions.
A very common approach for the preparation of silica shells is the Stöber method, in which as-prepared 
NP act as seeds for silica growth in an ethanol/water mixture and yield core-shell spheres. The prerequisite 
for this method is that the NP surface must have a significant chemical or electrostatic affinity for silica. 
Silanes can directly polymerize on oxide NP, such as Fe3O4 and TiO2, that have hydroxide-terminated sur-
faces; silane hydrolysis and condensation take place under basic conditions. However, for NP that do not 
have a passivating oxide layer in solution, such as noble metal and quantum dots, a ligand exchange using 
3-(trimethoxysilyl)propyl methacrylate and APTES [196] is necessary to render the particles hydrophilic 
before the Stöber method is applied to grow thicker silica shells. The ligand exchange mechanism will be 
discussed in the next section. In 2003, Graf et al. developed a simpler and faster method based on the use of 
poly(vinylpyrrolidone) (PVP), which has been shown to adsorb onto a wide variety of colloidal particles [197, 
198]. Upon PVP adsorption, the particles are transferred into a solution of ammonia in ethanol and directly 
coated with a silica layer of variable thickness by the addition of TEOS in a seeded growth process [197]. The 
particle stability and homogeneity of the coating shell are significantly affected by the molecular weight of 
PVP. Longer PVP chains improve the stability of the particles but lead to a rough surface coating. Thus, the 
optimal PVP lengths for coating different-sized NP usually have to be determined empirically.
The reverse microemulsion method is an alternative approach for silica shell formation. This method 
provides nanoreactors for the confined synthesis and silica coating of nanoparticles [187]. It can be applied 
to both hydrophilic QD stabilized with 3-sulfanlpropanoic acid or sulfanylacetic acid and hydrophobic QD 
prepared by the trioctylphosphine/trioctylphosphine oxide method [199]. In a reverse microemulsion, small 
water droplets are stabilized by a surfactant in a hydrophobic continuous phase. Hydrolysis and condensa-
tion of the silica precursor (e.g. TEOS) take place at the water-oil interface or in the water phase, resulting in 
highly uniform silica particles [200]. Hydrophilic QD coated with 3-sulfanylpropanoic acid or 2- sulfanylacetic 
acid transfer easily into the small water droplets, where silica growth occurs. For hydrophobic QD, hydrolyzed 
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TEOS molecules replace the original hydrophobic ligands, facilitating the transfer of the QD into the hydro-
philic interior of the micelles. The reverse microemulsion method has better control over particle size and size 
distribution than the Stöber method [201].
4.2   Ligand exchange
The use of small ligands that can replace the initial as-synthesized surface coating is a popular strategy for 
NP surface modification [202]. Highly crystalline and uniform NP are prepared in organic solvents at high 
temperatures using a stabilizer-modified surface that controls growth and prevents association during syn-
thesis. This normally yields hydrophobic NP; ligand exchange is then used to render the NP hydrophilic and 
suitable for biomedical applications [203].
Ligand molecules usually have two parts: the anchoring groups and the functional groups. The former 
bind the ligand onto the NP surface with high affinity, while the latter provide colloidal stability and function-
ality for further applications [202]. The choice of ligand depends on the core materials, particle size, and the 
solvent used. For example, QD and noble metal NP have surfaces that can easily bind thiols, disulfides, phos-
phines, and amines [102]. Metal oxide NP surfaces typically bind phosphonic acids and carboxylic acids [204].
Trioctylphosphine/trioctylphosphine oxide-coated quantum dots are usually transferred to aqueous 
solution by replacing the original hydrophobic ligands with hydrophilic thiol-based ligands, such as 2-sul-
fanylacetic acid, 3-sulfanylpropanoic acid, 11-sulfanylundecanoic acid, or 2-sulfanylsuccinic acid. Bidentate 
and multidentate molecules (for example, 6,8-disulfanyloctanoic acid [205, 206], and carbodithioate ligands 
[207]) have also been developed, as they are more strongly anchored to the NP surface and provide longer-
term colloidal stability than monodentate ligands. The carboxylic acid groups on these ligands also increase 
NP colloidal stability by charge repulsion and have flexible conjugation sites [208]. At the appropriate pH, 
other charged ligands with quaternary amine, tertiary amine, or sulfonic acid groups can also endow NP with 
excellent colloidal stability [209].
A second strategy for ligand modification is surfactant addition, during which the hydrophobic moiety 
of the surfactant associates with the hydrocarbon chain of the initial surface ligands, while the hydrophilic 
groups are exposed on the surface of the NP, rendering them water soluble [64]. CTAB is a widely-used sur-
factant and a known phase transfer agent. When dodecylamine-capped gold nanoparticles in chloroform are 
mixed with water containing CTAB, the hydrocarbon chain of CTAB assembles on the dodecylamine layer by 
hydrophobic interaction and the positively charged ammonium moieties extend into the solution, resulting 
in transfer of the hydrophobic nanoparticles into the aqueous phase [210].
4.3   Polymer coating
ENM that are designed for biomedical applications may be recognized as foreign objects and therefore elimi-
nated from the blood stream by the reticuloendothelial system [211, 212]. To avoid premature ENM clearance 
by the immune system and prolong their half-life in circulation, it is common to introduce “stealth” proper-
ties [213] by surface modification with biocompatible polymers [214, 215]. The preferred method is the adsorp-
tion or grafting of poly(ethylene oxide) (PEO), a linear polymer consisting of repeat units of –CH2-CH2-O-. 
A version of this polymer, terminated on both ends with –OH groups, is very well known as poly(ethylene 
glycol) (PEG). The two terms are used in the literature interchangeably. The systematic term PEO is used more 
in chemical and polymer sciences, while the trivial term PEG is very common in biological and material sci-
ences. In fact, the popularity of the trivial term PEG gave rise to the word ‘PEGylation’ and its analogues to 
describe the process of attaching segments of PEO to virtually any object or molecule. The term PEGylation is 
now extensively used across many scientific disciplines (including polymer science) and is also used in this 
document. We will however, refrain from using PEG, replacing it with the IUPAC-recommended, systematic 
term PEO.
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PEGylation of NP can be accomplished by covalently grafting, entrapping, or physically adsorbing PEO 
segments to the NP surface [216–219]. There are two synthetic approaches: a one-pot method where in  situ 
formation of NP and polymer coating take place concurrently, and a two-step method where the NP are first 
prepared and then coated with polymer [212]. Physisorption of PEO onto gold NP surfaces can be achieved 
through the one-pot method. An aqueous mixture of gold precursor and PEO is bombarded with synchrotron 
X-rays and PEO-gold NP are formed [220]. Covalent bonding is more complicated, since a thiol-functional-
ized PEO is used to passivate the gold surface with thiol groups and form a poly(ethylene oxide) layer on 
the NP surface. Both the PEO molecular weight and the type of anchoring ligand affect the stability of the 
PEO-coated NP [221]. Gold NP coated with high-molecular-weight PEO are more stable than those with low-
molecular-weight PEO, while NP coated with thioctic acid-anchored PEO exhibit higher colloidal stability 
than NP coated with thiol-anchored PEO [222]. The PEO coating can be further functionalized with additional 
moieties, such as antibodies, proteins, dextran, and DNA.
PEGylation of metal oxide NP usually involves introducing a silane between the surface and the PEO 
layer. This approach can be achieved either by reacting the NP with silanes and then functionalizing with 
PEO, or by reacting NP with commercially available PEO-siloxane. In the latter case, oleic acid-capped Fe3O4 
NP undergo a ligand exchange reaction with PEO-siloxane in toluene, and the PEO coated NP are soluble 
and stable in aqueous solution [223]. One-pot PEGylation of metal oxide NP is usually achieved in one of 
two ways: co-precipitation of salts or thermal decomposition of metallorganics in the presence of polymer. 
In the case of co-precipitation, PEO-coated Fe3O4 NP with various sizes have been synthesized by treating 
iron(II) and iron(III) solution with a base in the presence of PEO-containing graft copolymer, poly(glycerol 
monoacrylate)-g-poly(PEO methyl ether acrylate). The polymer block is chemisorbed to the particle surface 
by the coordination of 1,2-diols to the Fe atoms while the PEO block extends into the water [224]. Similarly, 
PEO-gallol can be coated onto Fe3O4 NP. The high binding affinity of the gallol and trihydroxybenzene units 
toward iron oxide allow a successful re-dispersion of freeze-dried particles [225]. Another one-pot synthesis 
of Fe3O4 NP functionalized with monocarboxyl-terminated PEO is achieved by the thermal decomposition of 
ferric triacetylacetonate (Fe(acac)3) in the presence of carboxy-PEO via coordination between carboxylic acid 
and Fe on the NP surface. Particle size is determined by the molecular weight of carboxy-PEO and the concen-
tration of Fe(acac)3, as well as by the ratio between them [226].
Block polymers are even more powerful NP stabilizers than homopolymers because they undergo phase 
separation and exhibit unique properties, such as surface reactivity, elasticity, selectivity, and resistance 
[227]. For example, degradable PLAGA NP can be coated with an amphiphilic PEO-PLA diblock copolymer, 
in which the hydrophobic PLA block adsorbs on the PLAGA surface and the hydrophilic PEG block extends 
from the NP surface and forms a protective coating [228]. However, such physically adsorbed polymers may 
not be stable and may undergo desorption in vivo due to replacement by blood components with higher 
affinity to the NP surface. Therefore, covalent binding of polymer is preferred in order to increase coating 
stability. A series of amphiphilic di-block copolymers of biodegradable PLAGA or PLA with PEO has been 
produced through ring opening polymerization of monomers in the presence of monomethoxy PEO [229]. 
Different solubility of the two blocks results in phase separation and a core-shell structure can be formed 
by an O/W emulsification procedure [230]. Although it is generally accepted that PEO-based coatings repel 
proteins, some poly(ethylene oxides) seem to be compatible with proteins. For example, a surface modified 
with PLA-PEO was reported to be able to adsorb proteins [231], provided that these proteins were present at 
their physiological concentrations [232].
4.4   Surface coatings of carbon nanotubes
Despite the promising biomedical applications of CNT, the high cytotoxicity attributed to their highly hydro-
phobic surface and their lack of biodegradability [233] limits their use in many biological systems. There-
fore, surface modification and functionalization of CNT to improve their solubility and biocompatibility has 
become a prerequisite for their applications. Many studies have shown that increased solubility of function-
alized CNT improves their performance and lowers their toxicity [234, 235], as they have low association and 
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can be taken up into cells without decreasing cell viability [236]. Functionalization strategies fall into two 
categories: covalent and noncovalent functionalization.
Covalent functionalization is based on the covalent linkage of functional entities onto the nanotube’s 
carbon scaffold [237]. The reaction occurs with a change of hybridization of the carbon atoms from sp2 to sp3 
with concomitant disruption of extended π-conjugation, leading to the introduction of defects in the nano-
tube structure with consequences for electron-acceptor and/or electron transport properties [238]. Oxidative 
purification is one of the most common functionalization techniques and can be achieved by using nitric acid 
[239–241], sulfuric acid [242], piranha solution [243], or gaseous dioxygen [244, 245] as an oxidant. Through 
this method oxygen-bearing functionalities, such as hydroxy, carbonyl, and carboxylate groups, can be intro-
duced to CNT, while residual metallic catalyst and carbonaceous impurities can be removed [246].
Noncovalent functionalization is achieved through weak interactions (π-π stacking, electrostatic inter-
actions, hydrogen bonding, and van der Waals forces) between molecules and CNT sidewalls. This helps to 
increase the water miscibility of CNT and leaves the polyaromatic scaffold unperturbed. The sp2 nanotube 
structure of CNT and their electronic characteristics are preserved [247]. Generally, small aromatic molecules 
are the ideal candidates to bind to CNT sidewalls and function as sites for further derivatization [248]. Pro-
teins are shown to be able to bind to CNT surfaces via a covalent sidewall functionalization. As such, a variety 
of proteins have been successfully immobilized on SWCNT functionalized by 1-pyrenebutanoic acid succin-
imidyl ester, in which the pyrene moiety adsorbs onto the sidewalls of SWCNT via π-π interactions [249].
Adsorption of surfactants onto a CNT surface is another widely used method that can enhance the sta-
bility and dispersibility of CNT. Self-assembly of surfactants on the CNT sidewalls changes the surface from 
hydrophobic to hydrophilic and therefore reduces the CNT cytotoxicity [250]. Surfactants such as sodium 
dodecyl sulfate, lithium dodecyl sulfate, CTAB, and Triton-X have been shown to disperse CNT effectively 
[151]. Finally, coating CNT with functionalized polymers is a common strategy to impart biocompatibility 
and solubility of the nanomaterial. For example, in the case of fluorescein-polyethylene glycol, the hydro-
phobic aromatic fluorescein group binds to the sidewall of SWCNT (likely via π-π stacking), while the PEO 
group extends into the water [251]. Other polymers, such as poly(vinyl pyrrolidone) [243, 252], poly(vinyl 
alcohol) [253], and poly(ethylene oxide) [254], have also been reported to modify CNT surfaces via non-cova-
lent adsorption.
4.5   Biomolecule recognition
The attachment of biomolecules capable of specific target recognition (e.g. ligands for membrane receptors/
transporters, enzyme substrates, RNA/DNA, antibodies, or aptamers) to a NP surface is a universal strategy 
with many applications. Information on strategies for conjugation of NP and biomolecules (bioconjugation) 
can be found in an extensive (over 150 pages) review [177]. A variety of methods have been developed, includ-
ing protein and DNA attachment to amine-reactive surfaces [255, 256], immobilization of biotin-activated pro-
teins on streptavidin-coated surfaces [257], and specific attachment using an intermediate protein coupled 
directly to the surface (e.g. Protein A or Protein G) [258, 259]. Interest in this area continues unabated 30 years 
after the invention of the first protein microarray systems (for a great review of the “ligand assay” history, see 
[260]). In general, the choice of a suitable immobilization strategy is determined by the physicochemical and 
chemical properties of both the nanoparticle surface and the biomolecules. Several comprehensive reviews 
and books dealing with useful immobilization techniques were published in the past few years [261–266]. We 
focus here on antibodies, since they are excellent targeting agents due to their large epitope space and high 
affinity for their antigen. For example, they have the capacity to recognize disease biomarkers, e.g. on the 
surface of cancer cells, which makes antibody-coated NP useful for biomedical diagnostics or bio-imaging.
There are two general methods for generating antibody-coated NP: passive adsorption and covalent 
attachment. Passive adsorption is straightforward to conduct, cost efficient, and leads to the adsorption of 
protein layers (coronas) on the NP surface [179]. However, because the proteins are immobilized non-cova-
lently, they can be removed and replaced by other biomolecules that exhibit higher affinity towards the NP 
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surface. Moreover, changes in antibody conformation or local pH can influence an antibody’s isoelectric 
point and subsequently its electrostatic interactions with the NP surface, leading to more rapid desorption 
of the targeting antibody. Although this method of conjugation of biomolecules is not very popular for drug 
delivery systems, it is widely accepted in biomedical diagnostics. One of the best examples is the passive 
adsorption of antibody-coated Au NP on a gold surface for use in pregnancy tests [267].
The majority of covalent coupling strategies that are applied to NP utilize standard chemistry employing 
-NH2/-COOH groups, which was first exploited for radio- and fluorescent-labelling of enzymes and proteins 
[268] (Fig. 5). One of the simplest examples of covalent conjugation of antibodies to NP involves the use of 
carbodiimide agents. For example, the zero-length 1-ethyl-3-[(3-dimethylamino)propyl] carbodiimide hydro-
chloride (EDC) reacts with carboxylated NP in the presence of sulfo-N-hydroxylsulfosuccinimide (sulfo-NHS) 
to form amine-reactive sulfo-NHS esters. The subsequent addition of antibodies results in coupling between 
the NP and primary amines on the antibody to form a stable amide bond. Unfortunately, the reaction is highly 
inefficient and thus requires a high excess of antibody. Typically, only about 1 to 20 % of the antibody used 
during the conjugation procedure can be coupled to the NP [269].
Another common approach to covalently coupling antibodies on the NP surface is based on two subse-
quent chemical reactions employing a variety of hetero- and homo-functional linkers [270]. The use of linkers 
is important, because they act as a spacer between the protein and the NP surface, thus avoiding denatura-
tion of the typically expensive biomolecule and undesirable biomolecule-nanoparticle interactions [271]. 
There are many commercially available bi-linkers, for example glutaraldehyde [272], adipic acid [273], and 
succinic anhydride [274, 275]. Using glutaraldehyde, the biomolecule of interest is immobilized directly via 
Schiff base formation. In many other cases, additional reagents are required for activation. Unless the Schiff 
base linkage is stabilized by a borohydride-reduction step, the binding can be easily reversed. Furthermore, 
the chemistry of glutaraldehyde is rather complex and this compound is highly toxic. Gubala, et al. previ-
ously demonstrated the advantages of multivalent linkers such as dendrimers in bioconjugation reactions 
and compared the effect of using dendrimers of increasing generation number on NP stability [270]. Due to 
the uniform and hyperbranched nature of such starburst macromolecules, a significant increase in conjuga-
tion efficiency and reaction kinetics was observed [276].
It is also noteworthy that the synthesis of antibody-nanoparticle conjugates is usually plagued by low 
coupling efficiencies, resulting in the use of large quantities of antibody and high cost of reagents. Because 
nonspecific antibody coupling methods do not result in site-specific binding, the orientation of the antibod-
ies on the NP surface is not controlled and the binding epitopes may not be accessible for target recogni-
tion. Approaches that attempt to control the site-specific orientation of antibodies focus on the Fc portion 
of IgG. For example, oxidizing the oligosaccharide moieties of the Fc region generates aldehydes, which can 
be reacted with amine- or hydrazine-terminated surfaces, resulting in the variable region of the antibody 
being oriented away from the ENM surface and available to recognize target molecules. Protein A can also 
be used for site-specific antibody immobilization, since it binds the Fc region of IgG. If immobilized to ENM 
surfaces, Protein A can bind the Fc region of antibodies to produce a bio-functionalized nanomaterial with 
the Fv region available for target recognition. Target recognition can also be improved by employing mono-
clonal antibodies, which bind a single specific epitope of an antigen. However, because monoclonal antibod-
ies are expensive and protein coupling strategies are inefficient, polyclonal antibodies are often preferred, 
despite their reduced biomolecular recognition capability and potential for non-specific binding. The choice 
of antibody is therefore application-dependent. Regardless of the method used to attach biomolecules, it is 
important to evaluate the biological performance and the purity of the bio-functionalized NP. In doing so, the 
‘fraction of active biomolecules’ on the NP surface (i.e. the fraction of biomolecules capable of target recog-
nition) can be elucidated and the bioconjugation strategy effectively optimized [1]. This can be governed, in 
part, by the density and orientation of biomolecules on the ENM surface.
Liu et al. [277] took this into consideration when assessing the performance of enzyme-coated 18 nm gold 
NP. The authors studied protein-coated NP activity by (i) specifically orienting the enzyme (E. coli inorganic 
pyrophosphatase, EC 3.6.1.1) on the NP surface and (ii) varying the surface density of bound enzyme. The 
gold NP coated with specifically oriented enzyme exhibited 91 % activity relative to that of native enzyme in 
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solution, while the NP with randomly oriented enzyme exhibited 58 % activity. It was also shown that saturat-
ing the NP surface with proteins did not greatly affect protein activity. The authors therefore concluded that 
biomolecule orientation had a larger influence on the activity of these bio-functionalized NP.
Fig. 5: Examples of the most popular chemical reactions for antibody--NP conjugation. a) One-step procedure using unmodified 
antibodies and coupling agent EDC or EDC/NHS (sulfo-NHS for better solubility in aqueous media); b) Two-step process using 
monovalent linkers such as glutaraldehyde and unmodified antibodies; c) Two-step process using multivalent linkers such as 
dendrimers and unmodified antibodies; d) One-step process using modified antibodies (fragmented by (2S,3S)-1,4-bis(sulfanyl)
butane-2,3-diol, known as 1,4-dithio-D-threitol (DTT) or 2-sulfanylethan-1-ol, also known as 2-mercaptoethanol (2-MEA) – extra 
step) and heterofunctional bi-linkers such as sulfo succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate [sulfo-SMCC] 
or sulfo- succinimidyl (4-iodoacetyl)aminobenzoate [sulfo-SIAB]; e) One or two steps procedure using oxidized antibodies 
(usually by periodates); the antibody-NP linkage is reversible, therefore further reduction with borohydrides can be advanta-
geous as it generates a stable covalent bond; f) One-step reaction between streptavidin-coated NP (many types are com-
mercially available) and biotinylated antibody (also many types commercially available). Other types of site-specific antibody 
immobilization methods such as via His-tagged antibodies and NTA-Ni coated NP or via Protein A/G – coated NP (for binding to 
Fc region of immunoglobulins) are less common and therefore not illustrated in this figure. The cartoons used in this illustration 
show a solid NP, however NP are also often fabricated from porous material.
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In summary, the conjugation of antibodies that are able to retain their specific activity and molecular 
recognition capacity on the nanoparticle surface still remains a challenging task. It is regrettable that some 
important factors, such as the effects of the cross-linker on the colloidal stability of the NP, the development 
of robust and simple methods of conjugating antibodies in an epitope-oriented fashion on the NP surface, 
and the antibody-binding efficiency of NP, have still not been fully addressed. This is alarming, especially 
since NP size and surface properties are considered important parameters for mediating the biocompatibility 
of new materials used in nanomedicine [33]. Exploring these important issues may lead to increasingly more 
robust methods for the conjugation of antibodies to NP surfaces.
5   Size-dependent features of nanomaterials
Some nanomaterials have novel properties that are not exhibited by the bulk material, leading to novel prop-
erties and applications [278]. Examples of such properties include light refraction of TiO2 particles, unique 
optical features of quantum dots, novel catalytic or photocatalytic activities (e.g. of gold nanoparticles or 
nanoclusters), magnetic properties for imaging, or self-assembly of micelles to defined diameter. Because of 
the great importance of size in characterizing nanomaterials, it seems tempting to provide precise particle 
diameters at which the novel behavior is observed. However, that range is material-specific, meaning gener-
ally valid size limits for nano-specific characteristics cannot be given. Even if a nanosized material does not 
have nanosize-specific physiochemical features, the small size itself may be advantageous for body-close 
applications. These features include enhanced solubility, faster degradation in the organisms and environ-
ment, potentially higher catalytic rate due to the larger surface, as well as improved fluidity (e.g. when used in 
ointments). Table 1 lists examples of approximate sizes at which specific size properties have been observed 
for some nanomaterials.
A similar situation prevails with regard to size-dependent biological features that affect the fate of NP 
in a biological system (Table 2). For example, the pores for renal filtration have a diameter of about 8 nm. 
Table 1: Size-dependent properties of ENM compared to bulk materials. The values for size limits are approximations and will 
vary with the nanomaterial composition and surface characteristics.
Approximate size range Selected Material Properties
1–5 nm Novel catalytic activities
Self-restricted size of micelles
2–10 nm Optical properties of quantum dots
20–30 nm Changes in magnetic properties
16–40 nm Changes in refractive index
1–100 nm Range of superparamagnetism
100–500 nm Properties tend to approach those of the bulk material
Table 2: Size-dependent features of ENM compared to bulk materials. The size-ranges are approximations and should be 
 considered as a rough guide; material-dependent deviations often occur.
Size limits Biological features relevant for NP transport in the organism
<0.8 nm Pores of tight junctions between cells of biological barriers (e.g. intestine)
8 nm Diameter of renal filtration pores
<50 nm Cell uptake by pinocytosis in some cell types
~50–100 nm Cell uptake by endocytosis
~100–200 nm Cell uptake by pinocytosis possible
<300 nm Intrusion of inhaled particles into the lowest (smallest) parts of the airways
~500 nm Cell uptake by phagocytosis
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Therefore, NP with diameters of up to 8 nm may be expected to be efficiently filtered. However, additional 
parameters, such as the surface charge, may strongly influence renal filtration. As a result, administered NP 
smaller than 8 nm do not necessarily appear in the urine, either because the kidney does not allow them to 
pass or because alternative elimination routes or storage prevail. Although ranges of up to 300 nm [279] or 
500 nm [21] have been proposed to encompass important physiological behavior of ENM, the characteristic 
range for specific size-dependent behavior will vary with both the nanomaterial composition and the biologi-
cal system of interest (see manuscript part 2).
6   Characterization methods for nanomaterials
The characterization of ENM is a key step to ensure the reproducible commercial production of materials with 
the same properties. Any attempt to compare the utility or efficacy of an ENM for a specific application or to 
assess its potential harmful effects requires that the material be adequately characterized after purification 
for all properties that are relevant to the specific end use in the relevant environment. Incomplete characteri-
zation of ENM is recognized as a major drawback in many publications, making it difficult to reproduce and 
validate experiments. Furthermore, purchased materials do not always conform to the material specifications 
provided and even subtle changes in synthesis, purification, storage, and/or handling conditions may cause 
significant variation in physico-chemical properties. The challenges associated with adequate characteriza-
tion are compounded by the fact that there are many relevant nanomaterial properties and it is not always 
obvious which ones are important for a specific application. Moreover, the optimal method(s) for assessing 
the property of interest may not be known or the technique may not be readily available. Considerable effort 
is being expended to address this situation. There is a strong demand for a read-across system that will 
provide guidance on the characterization of specific classes of ENM, particularly from a regulatory perspec-
tive [280]. To date, this has been a challenging task, partly because there are many ways to organize ENM 
into classes, partly because the important properties usually depend on the specific application, and partly 
because the optimal method (or methods) for a particular property is not always well-established.
More than twenty physico-chemical properties of nanomaterials have been identified as important for 
the assessment of environmental, health, and safety risks for nanomaterials [281–283]. Generally, these prop-
erties are grouped into categories, such as composition and structure, size/shape, and surface properties. 
Table 3 summarizes the major properties. With a few differences for some less commonly measured proper-
ties that apply to a relatively small subset of nanomaterials, the categories in Table 3 are representative of the 
bulk of the literature. The characterization of nanomaterials presents a number of challenges [284] and it is 
recognized that, in most cases, multiple techniques are required to obtain reliable and complete informa-
tion [284–286]. This is often difficult, since many academic and industrial labs may not have access to the 
range of methods and expertise necessary. Furthermore, different analytical methods for a specific prop-
erty frequently do not measure the same parameter (i.e. the measurand is method-dependent), which makes 
comparisons difficult. In addition, the measurement conditions used in specific analytical methods can vary 
from laboratory to laboratory due to a lack of standardization. Another complication is that the properties of 
the material are often both time- and environment- (temperature, light, medium) dependent. Therefore, it is 
important to not only have a purified and well-characterized pristine material, but also to understand how its 
properties change with time and environment. Lastly, either the analytical sample preparation or the analysis 
technique (e.g. damage from electron or ion beams) may alter the property of interest.
6.1   Pre-analytics and sample preparation
Sample preparation is an important factor for consideration for all nanomaterial characterization methods. 
In all cases, the sample must be carefully purified to remove all excess reagents or undesired by-products 
resulting from either the initial synthesis or surface modifications. The purification method varies depending 
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Table 3: Methods for characterizing nanomaterials.
Nanomaterial 
propertya
Analytical Method Comments
Composition/
presence of 
contaminants
Elemental analysis
Nuclear magnetic resonance
Mass spectrometry (coupled with gas or 
liquid chromatography or inductively coupled 
plasma)
Raman and Infrared spectroscopy
UV-VIS and fluorescence spectroscopy
Optically coupled plasma-optical emission 
spectroscopy
Endotoxin and pyrogen assays
Bulk chemical composition
Presence of surface coatings, dispersants or 
stabilizers
Presence of impurities/contaminants
Detection of endotoxin and pyrogen impurities 
is important for toxicological evaluations
Crystal structure/ 
Crystallinity
X-ray diffraction
Nuclear magnetic resonance
X-ray diffraction also gives crystal size
Primary particle 
size, particle size 
distribution
Electron microscopy
Scanning probe microscopy
Light scattering (dynamic, multiple or static 
light scattering)
Nanoparticle tracking analysis
Differential mobility analysis (scanning 
mobility particle sizing)
Centrifugal liquid sedimentation (analytical 
ultracentrifugation)
Gel filtration
Scanning ion occlusion spectroscopy
Field flow fractionation
Small angle X-ray scattering
Samples can be liquid suspensions, or dry or 
aerosol particles, depending on the method
Size is method dependent (see Table 3)
Methods can be classified as:
–  particle counting (both imaging and non-
imaging methods),
–  ensemble (all particles in sample are 
measured at same time) or
–  separation/fractionation (particles are 
separated based on size, prior to analysis 
by either particle counting or ensemble 
methods)
Shape, aspect 
ratio
Electron microscopy
Atomic force microscopy
Light scattering methods
Microscopy methods are best suited to 
identifying particle shape and aspect ratio
Light scattering data can be used in some cases
Particle 
association
Electron or scanning probe microscopy
UV-VIS or fluorescence spectroscopy
Microscopy methods provide direct information 
on association of particles
Most other particle sizing methods do not 
distinguish between large particles and 
clustered/associated particles
Optical spectroscopy provides information in 
some cases
Dispersibility Particle sizing methods
Turbidity
Rheological measurements
Changes in dispersibility are generally 
assessed by light scattering methods or 
turbidity or rheology measurements
Surface area Gas or liquid adsorption isotherms (Brunauer-
Emmett-Teller)
Adsorption method is only suitable for dry 
samples; sample association is a limitation for 
some nanomaterials
Surface Charge Measurement of electrophoretic mobility by 
either optical or acoustic methods
Zeta potential calculated from electrophoretic 
mobility
Surface 
functional 
groups
Nuclear magnetic resonance
Secondary ion mass spectrometry
Raman and Infrared spectroscopy
X-ray photoelectron spectroscopy
Auger electron spectroscopy
Elemental analysis
Titration (acidic/basic groups)
Fluorescence and UV-VIS assays
Ellipsometry
Detection using antibodies
Important for quantifying extent of surface 
modification, type of functional group, 
presence of surface contamination
Most of these methods (with exception of SIMS 
and optical assays) are not generally used 
for analyzing adsorbed proteins or covalently 
attached biomolecules
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on the material composition with dialysis through semi-permeable membranes with an appropriate cut-off, 
chromatography, centrifugation and ultrafiltration being among the most commonly used techniques. It is 
important to ensure that the starting sample is homogeneous and that the sub-sample to be analyzed is rep-
resentative of the overall material. One of the first considerations is whether the sample is obtained as a dry 
powder, a liquid suspension, or an aerosol, since this will dictate the choice of appropriate methods. In many 
cases, a dry sample may require dispersion in a solvent prior to analysis; in such cases the dispersion method 
and the solvent have to be selected and optimized. For aqueous suspensions, factors such as the buffer, the 
pH, and the presence of salt can all have a significant effect on the nanomaterial properties. The use of salt 
concentrations that have physiological ionic strength may cause the association of nanomaterials due to the 
screening of electrostatic charge on the particle surface. The concentration of the ENM is also important, as 
it may control the association of the particles. For aerosol samples (generally for detection/characterization 
of environmental or workplace contaminants), the collection method must be carefully chosen to ensure a 
representative sampling of the material at adequate concentrations for the analytical method to be used. 
Additional method-specific factors are discussed in the sections below.
The methods summarized in Table 3 are applicable to most pristine ENM (either as dry materials or sus-
pensions), although in some cases the sample size requirements may be a limitation. However, many of the 
characterization methods are challenging or impossible to utilize for nanomaterials in the more complex 
environments typical of biological or environmental samples. Finally, there are typically multiple methods 
that can be used to measure a specific physicochemical property. The selection of the “best” method (or 
methods) for a specific ENM will be based on compromise between the following factors: cost, availability, 
skill of operators, required resolution/sensitivity, sample format, and accuracy/precision required for a spe-
cific end use of the ENM. In summary, it should be stressed that the selection of the proper method to obtain 
a homogeneous sample and the appropriate analytical method are key to obtaining reliable data.
6.2   Composition/purity/structure
The composition of a nanomaterial is one of the most basic properties of interest and can frequently be meas-
ured by techniques such as elemental analysis or spectroscopic methods that are typically employed for bulk 
materials (Table 3). This is reasonably straightforward for single-element or single-compound nanomaterials 
but is more challenging for core-shell particles (e.g. QD or silica-coated NP). In these cases, a combination 
of bulk and surface sensitive methods may be required for compositional analysis. Note that, although the 
chemical composition is generally defined by the synthesis method employed, the presence of impurities 
or contaminants frequently has a major impact on the behavior of the material. The large surface area-to-
volume ratio of nanomaterials increases the possibility that the impurity is near or on the surface, where it 
may more readily modify the properties of the nanomaterial. In some cases, the amount of impurity present 
may be below the detection limit of a specific analytical method.
Nanoparticles are commonly synthesized with a variety of surface coatings to either stabilize or disperse 
the material, which must also be taken into account. The amount of surface coating can vary considerably 
Nanomaterial 
propertya
Analytical Method Comments
Chemical 
reactivity/
stability
A wide range of methods can be used to 
assess reactivity by measuring final products 
(see composition) and their rates of formation
Thermogravimetric analysis for thermal 
stability
Includes catalytic reactivity, photochemical 
reactivity, thermal stability
Dissolution of some nanomaterials may 
occur in aqueous or biological media or in 
environmental samples
aMechanical, electrical and optical properties are important for many nanomaterial applications but are not included here.
Table 3 (continued)
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depending on the sample history. It should be noted that additives used to stabilize or disperse the material 
may be more challenging to detect and quantify than covalently attached surface functional groups, which 
typically do not change with the nanomaterial environment. Of particular importance for biological studies is 
the presence of endotoxins (pyrogens) which are common contaminants and can lead to toxicity effects that 
have nothing to do with the nanomaterial itself. The suitability of several commonly used tests for endotoxins 
has been evaluated, highlighting the fact that nanomaterials interfere with some of the assays [287, 288].
X-ray diffraction is the most widely used method for analyzing the structure of crystalline materials. The 
lattice spacing can be determined from the angle of constructive interference when X-rays scatter from crys-
talline materials. The powder method (Debye-Scherrer) is used for nanomaterials which are generally studied 
as dry powders. Analysis of the peak position and intensity is used to identify and quantify the phase compo-
sition of the sample. The general challenges associated with obtaining structural information for nanomate-
rials using X-ray diffraction and other surface characterization tools have been discussed [289].
6.3   Shape, size and size distribution, aspect ratio
It is generally recognized that measurements of the size, size distribution, and shape (including aspect ratio 
for non-spherical particles) are among the top priorities for most, if not all, nanomaterials. There are three 
general approaches for obtaining size distributions (see Fig. 6). The first relies on particle counting methods, 
typically electron or scanning probe microscopies, which provide details on the shape of particles and (in 
some cases) the presence of associated particles. The second approach relies on ensemble methods that 
measure all particles in the solution. A third classifying or fractionation approach involves the pre-separation 
of nanomaterials based on their size prior to analysis by either particle counting or ensemble methods and 
is particularly useful for samples with broad size distributions. As reviewed recently, there are trade-offs 
for each approach [290, 291]. Careful consideration of the sample characteristics, the time and resources 
available, and the required measurement accuracy are necessary to select the most appropriate method, or 
frequently, combination of methods. Table 4 summarizes the various particle sizing methods according to 
these three categories.
Fig. 6: General categories of particle sizing methods. Higher resolution methods usually assess particles individually, lower 
resolution techniques do not separate particles and provide an average number from the bulk. Adapted from [290].
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6.3.1   Microscopy particle counting methods
The shape and size of nano-objects can be assessed by either scanning or transmission electron microscopy 
(SEM, TEM), or by atomic force microscopy (AFM), all of which image individual particles and measure their 
size (length, width, or height) and shape (see Fig. 7). Based on the spatial resolution (see size range column for 
microscopy methods in Table 3) and the ability to deal with associated and/or non-spherical particles, micro-
scopy (often TEM) is frequently the primary characterization method for obtaining size distributions. Micro-
scopy is the only method that allows for the direct visualization of the shape and size of individual particles 
(and associated particles). Nevertheless, this is neither a rapid nor a straightforward process. Both electron 
microscopy and AFM require the sample to be deposited on a surface or grid and yield the most reliable informa-
tion for well-dispersed particles. Thus, sample preparation, including the dispersion of the initial dry samples 
and deposition on a suitable surface, often requires considerable optimization. The most common methods for 
sample preparation include (1) incubation of dilute samples of nanomaterials with an atomically flat surface 
or electron microscopy grid followed by washing, (2) drop-casting and drying, and (3) spin coating [292–294]. 
Although most preparation methods have the potential to select for a specific size or shape of particles during 
the sample deposition process, thereby limiting the ability to obtain data for a representative sample, this possi-
bility has rarely been examined. The use of surfaces with a charged coating is a common approach to ensure the 
immobilization of charged particles [292] and to help minimize association of particles. Although microscopy 
can provide information on clusters of particles, it is not usually possible to determine whether the associated 
particles are present in the initial sample or whether they are formed during sample deposition.
In addition to optimizing the sample preparation to ensure representative sampling and well-dispersed 
nano-objects, it is important to ensure that the sample is not damaged by the imaging conditions, for example 
by the intensity of the electron beam or the scanning action of an AFM probe. Obtaining size information on 
non-uniformly sized samples may require collecting images on different length scales to adequately resolve 
small and large particles, adding to the time and resources required. The measurement of a large number 
of individual particles (n) is required to determine the particle size distribution, with non-uniformly sized 
samples and/or lower measurement uncertainty requiring larger n. The ability to distinguish between two 
size distributions depends on the width of the distribution and the level of confidence required. The length 
of time required to analyze the dimensions of individual particles (excluding clustered particles) is fre-
quently considerably longer than that required for data acquisition and is a significant limitation to acquir-
ing size distributions based on large numbers of particles by microscopy. Automated approaches have been 
Fig. 7: Images of various types of ENM. (a, b, c) TEM images of gold nanoparticles with 3 different shapes (cubes [295]; spheres 
and nanorods imaged on Formvar grids [296]). (d, e) TEM images of titanium dioxide nanoparticles [297] and core-shell iron 
oxide nanoparticles [298]. (f) AFM image of polymer wrapped carbon nanotubes on mica with z-scale as color bar [299].
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employed in some cases, although so far with most success for well-separated spherical particles that have 
relatively narrow size distributions. Finally, particle counting methods can never interrogate more than a 
very small fraction of the sample, so it is important to ensure representative sampling, for example by split-
ting the initial sample and measuring multiple parts. Microscopy data is typically plotted as histograms that 
 illustrate the distribution of length and cross-section (width or height); the mean (number average), standard 
deviation (as a measure of the width of the distribution), and number of particles analyzed are reported. 
More advanced analysis methods that measure other parameters (aspect ratio, perimeter, circularity, etc.) 
are sometimes used for non-spherical particles and can be useful for distinguishing multiple populations 
within non-uniformly sized samples. Methods for particle size analysis and sampling for microscopy, as well 
as information on the general and technique-specific issues that are often encountered are summarized in a 
number of standards [300–303].
6.3.2   Particle counting by non-imaging methods
Nanoparticle tracking analysis (NTA) is a potentially useful alternative particle counting method. NTA meas-
ures the light scattered by particles in suspension as they diffuse within a focused laser beam that is aligned 
so that only particles in the focal plane of the collecting optics are illuminated [304]. The motion of individual 
particles is recorded using a charge-coupled device camera with high time resolution and the trajectory of each 
particle is calculated as the mean squared displacement, from which the diffusion coefficient can be deter-
mined (Fig. 8). The equivalent hydrodynamic diameter is obtained using a modified Stokes- Einstein equation 
that accounts for three-dimensional diffusion [305]. Since all particles in the laser beam are tracked sepa-
rately, this method provides a number count-based distribution (unlike ensemble light scattering methods) 
and can deal with non-uniformly sized samples. There are several requirements for obtaining reliable data, 
including optimization of the particle concentration and light intensity so that individual particles can be fol-
lowed over an adequate tracking length. This may be particularly challenging for highly non-uniformly sized 
samples. The data quality is affected by the scattering intensity from individual particles, which is in turn 
controlled by their composition. Finally, data analysis assumes spherical particles, a criterion which limits 
the applicability to non-spherical particles, and associated particles will appear as a single large particle, in 
contrast to microscopic methods which can often distinguish between individual and associated particles. 
Nevertheless, NTA is a time and cost-effective alternative to microscopy measurements for some samples and 
its ability to provide number-based distributions, even for uniformly sized samples (see Fig. 8, in which 100, 
200 and 300 nm particles are clearly distinguishable), is a significant advantage over ensemble methods such 
as dynamic light scattering (see below) [306].
Fig. 8: Nanoparticle tracking analysis for a sample containing 3 sizes of polystyrene beads. The software tracks many particles 
individually (a) and uses the Stokes Einstein equation to calculate their hydrodynamic diameters (b). The system has higher 
resolution output with more detailed size distribution of particles in a non-uniformly sized sample and provides the particle 
concentration. Source: EMPA, Switzerland.
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Scanning ion occlusion sensing (SIOS, also known as tuneable resistive pulse sensing, TRPS) is an 
emerging particle counting method that is based on the same principle as Coulter counting, but is applicable 
to nanometer-sized particles [307]. The method measures the change in resistance when a particle passes 
through a pore or channel; the change in resistance is proportional to the volume of electrolyte displaced 
and hence to the particle volume, which in turn is proportional to particle size. SIOS requires non-conductive 
particles and dispersion of the sample in an electrolyte. The magnitude of the change in resistance is propor-
tional to the particle-to-pore volume ratio, so that the sensitivity can be adjusted by varying the pore size. If 
the pore size is narrow but the particle still traverses it, then the volume of electrolyte displaced is large. Thus, 
the change in resistance detected, observed as a ‘pulse’, is distinguishable from background signal. Particle 
concentrations are obtained from the pulse frequency (i.e. the number of particles that traverse the pore per 
unit of time). SIOS provides volume-based size distributions based on the diameter of an equivalent sphere, 
although it is possible to model the behavior of non-spherical (elliptical) particles. Similar to NTA, the main 
advantage of SIOS is the ability to provide a number-based size distribution. However, the analysis of NP less 
than 100 nm can be challenging, as associated NP or multiple NP attempting to traverse the pore at the same 
time can result in pore blockage. When employing a larger pore size, the pulse generated by a single NP may 
not be discernable from background due to insufficient volume displacement.
6.3.3   Ensemble methods
Ensemble methods interrogate the entire sample, thus avoiding the sampling problem encountered with 
particle counting methods, and are generally rapid and easy to use. Nevertheless, they usually have lower 
resolution than particle counting approaches, often yield only an average size and do not work well with 
non-spherical or non-uniform nanomaterials. Despite these limitations, ensemble methods are widely used 
for routine measurements and are suitable for assessing batch-to-batch reproducibility of samples.
Dynamic light scattering (DLS) is the most commonly employed ensemble method and measures the 
time-dependent fluctuations in intensity of light scattered from particles suspended in liquid and undergoing 
Brownian motion. These intensity fluctuations are plotted as a correlation function from which the transla-
tional diffusion coefficient, Dt, can be calculated using the Cumulants method [305, 308]. The Stokes Einstein 
equation is then used to calculate the mean hydrodynamic diameter, dh. For a non-spherical particle, one 
obtains the equivalent hydrodynamic diameter, which is the diameter of a rigid sphere that diffuses at the 
same rate as the analyte particle. The intensity-weighted equivalent hydrodynamic diameter, dh, of solvated 
particles estimated from DLS will almost always differ from the diameter measured by microscopic methods. 
For spherical particles, the differences are primarily due to the electrical double layer, whereas the situa-
tion will be more complex for non-spherical particles. The scattering intensity is proportional to r6 (where r 
is radius of the scattering particle), which means that the scattered intensity from a 100 nm particle will be 
1 million times larger than that from a 10 nm particle. DLS is compatible with any type of nanoparticle that 
does not absorb at the laser wavelength and that gives a stable colloidal suspension, and the minimum detect-
able size can be as small as a few nm for materials with a large scattering cross section. Usually, samples are 
filtered to eliminate large clusters of particles and are measured in the presence of modest salt concentrations 
to minimize the electrical double layer.
The fit of the correlation function using the Cumulants method also provides the polydispersity index, PI, 
which is a dimensionless measure of the broadness of the size distribution. DLS works well for uniformly sized 
samples (polydispersity index <0.1), but is not recommended for samples with broad size distributions [285]. 
Although a range of algorithms have been used to fit the correlation curve to extract multiple components for 
non-uniformly sized samples, there is so far no generally accepted method for analyzing such samples. DLS 
provides intensity-weighted distributions that differ from the number-weighted distributions obtained from 
particle counting methods. The intensity-weighted distribution provided by DLS can be converted to a volume 
distribution using Mie scattering theory and the refractive index of the particle. The volume distribution has 
the advantage of more clearly showing signals due to small particles that have low scattering intensity and is 
shifted to lower apparent diameter. Although further conversion to a number-based distribution (to compare 
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to particle counting methods) is possible, each conversion leads to additional sources of error (see Fig. 9). 
Multi-angle light scattering (dynamic or static) has been employed to overcome some of the issues associated 
with DLS (for example the requirement to avoid multiple scattering events), but is still not widely used [309].
Small angle X-ray scattering (SAXS) provides information on the size and shape of particles in suspen-
sion [310]. The particle and the liquid phase must have different densities and the particle concentration 
must be low enough to avoid particle-particle interactions. The scattering data can, in principle, be fit to 
extract both size and shape information, but generally only for relatively uniformly sized samples of spheri-
cal particles that have a uniform density throughout (i.e. core-shell particles are problematic). As for other 
ensemble methods, SAXS is relatively fast and does not suffer from sampling issues. Neutron scattering has 
similar capabilities, but is only accessible at national facilities.
6.3.4   Fractionation or classifying methods
Fractionation methods separate particles of different sizes prior to their analysis by either an ensemble or 
particle counting method. Although these techniques are typically less reproducible and more difficult and 
time-consuming than ensemble methods such as DLS, the ability to resolve non-uniformly sized samples is 
a significant advantage. However, these methods are not able to distinguish between primary and associated 
particles; they separate and classify particles based on an equivalent spherical diameter [290].
Centrifugal liquid sedimentation (CLS) and analytical ultracentrifugation fractionate particles based on 
their rate of sedimentation induced by centrifugal forces. The rate of sedimentation depends on the particle 
density and size, with the Stokes equation used to calculate the Stokes diameter from the time required for 
the particle to travel a specific distance at a given angular velocity. This requires the particle density (which is 
assumed to be the same for all particles) as well as the density and viscosity of the liquid. A further constraint 
is that the density of the particles must be significantly higher than that of the liquid in order for sedimen-
tation to occur. It is also important to note that, similar to DLS, the Stokes equation calculates the equiva-
lent spherical diameter; non-spherical particles will orient to give maximum drag and will therefore settle 
at slower velocities. CLS typically uses one of two possible geometries. With the disc or line-start method 
the sample is introduced as a thin layer on top of the spinning liquid, whereas in the homogeneous method 
particles are initially distributed uniformly throughout the liquid. Commercial CLS detection systems use 
turbidity, optical absorption, or X-ray detection to monitor sedimentation of the particles. This method has 
an advantage over ensemble methods for non-uniformly sized samples and provides data that is more similar 
to a number-based distribution than the intensity-weighted data obtained from DLS.
Field flow fractionation (FFF) separates particles based on changes in their mobility as a fluid is pumped 
through a narrow channel in a laminar flow. The fluid moves more rapidly in the centre of the channel than at 
Fig. 9: Comparison of intensity, volume and number-weighted size distributions determined by dynamic light scattering for 
silica nanoparticles. The nanoparticles have an average hydrodynamic diameter of 98.9 nm based on intensity weighted data 
and a diameter of 82.6 nm from TEM. The x-axis is on a logarithmic scale. Source: National Research Council Canada.
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the edges and a field (gravitational, cross-flow, electric) is applied perpendicular to the flow direction, which 
pushes particles to the edge of the channel. Smaller particles diffuse more rapidly against the applied field 
towards the centre of the channel and will be eluted more rapidly. FFF separates particles according to their 
equivalent hydrodynamic diameter and requires calibration with standard samples with the same properties 
to provide size information from elution times. Since such standards are rarely available, FFF is typically 
combined with a detector (light scattering, refractive index, UV absorbance) for on-line size measurement. 
Fractions can also be collected and then analyzed by any of the particle counting methods. FFF as a fractiona-
tion method is well-suited to non-uniformly sized samples, but can only provide information on associated 
particles when combined with a microscopy method that can distinguish clusters from primary particles.
A cascade impactor separates airborne particles based on their aerodynamic diameter, using the inertial 
separation of solid or liquid particles in the gas phase. Since this method requires aerosolized particles, it 
is most frequently used for aerosol research or inhalation studies. Aerosolized particles are forced through a 
series of impaction plates arranged in order of decreasing particle size. At each individual stage particles in 
the aerosol stream with sufficient inertia will be trapped on the stage collection plate, while smaller particles 
with insufficient inertia will pass on to the next stage. Particles collected at each stage are analyzed gravi-
metrically or used for size or composition analysis. This method can use a large range of stages to cover a wide 
dynamic range, but it is prone to errors due to stage overlap and particle trapping on non-plate surfaces, both 
of which make it difficult to obtain accurate particle size distributions. Furthermore, the tendency for dry 
particles to associate is a limitation for many types of nanoparticles.
6.4   Comparison of particle sizing methods
The various particle sizing techniques described above are based on different physical principles and 
provide method-defined sizes. Since different methods give different sizes, it can be challenging to make 
comparisons. Examples include the differences between intensity- vs. number- vs. volume-based measure-
ments, as well as between the diameter of a dry particle as measured by microscopy and the hydrodynamic 
diameter measured by methods that analyze particles in suspension. It is still relatively rare to use multiple 
methods for routine characterization, although combinations of an ensemble method with a particle count-
ing approach are becoming more common. However, there are now a few detailed studies that compare 
results obtained using different techniques for the same samples. One recent interesting example used 
six different techniques to examine silica particles with sizes between 100 and 400 nm (see Fig. 10) [286]. 
Fig. 10: Number-weighted particle size distributions for nominally 100 nm silica nanoparticles measured by 6 analytical 
methods: Transmission electron microscopy (TEM), scanning mobility particle sizer spectrometer (SMPS), dynamic light scatter-
ing (DLS), scanning ion occlusion sensing (SIOS), nanoparticle tracking analysis (NTA), differential centrifugation sedimentation 
(DCS). Reproduced with permission from ref [286].
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The authors reported that, despite the different measurands for the various techniques, the reported size 
 distributions were all within one standard deviation for these spherical particles. They also highlighted the 
crucial importance of adequate optimization of the sample preparation method and measurement condi-
tions, the importance of reporting full particle size distributions, and the need for more reference materi-
als for the validation of protocols and measurement results. Related examples looking at a more limited 
number of techniques have emphasized similar conclusions [285, 294, 311]. So far, most measurements of 
this type have focused on spherical particles with relatively uniform particle sizes. Similar studies for more 
disperse samples and non-spherical particles would be very beneficial to better understand the key differ-
ences in the various particle sizing approaches.
6.5   Dispersion and particle association
Although dilute solutions of nanomaterials usually contain a relatively large fraction of isolated primary 
particles, dry nanomaterials exist primarily as strongly associated clusters of particles. In some cases, 
the associated particles may be very difficult to break apart without danger of disrupting the constitu-
ent particles [291]. Dry nanomaterials can sometimes be redispersed by simple dilution and shaking in 
an appropriate solvent (possibly with a stabilizing agent). However, usually more energy is required and 
the application of ultrasound to a suspension of particles is the most common way to separate associated 
particles. The energy and time required to redisperse nanomaterials will depend on the type of sample, 
its environment, and the instrument used. Guidelines for standardizing the measurement of sonication 
power and reproducible preparation of nanomaterial samples by sonication have been reported [312]. It is 
important to minimize the energy applied, since excess energy may cause chemical damage or break apart 
primary particles.
A 2012 report concluded that there is so far no method that can reliably distinguish whether a large par-
ticle is a cluster of primary particles or a single particle, while at the same time measuring the size of large 
numbers of constituent particles [291]. In some cases, clusters can be identified by microscopy, although 
it may not be possible to ascertain whether they were present in the initial sample or were formed during 
sample preparation. Repeating size measurements using a rapid method such as DLS before and after appli-
cation of sample dispersion methods can frequently give some information on changes that are related to 
breaking up clustered particles. Nevertheless, the measurement of sizes and the extent of association for 
complex samples that contain mixtures of primary particles and clusters remains a significant challenge. 
Unfortunately, such complex “real-world” samples are more common than dilute solutions of well-dispersed 
nanomaterials.
6.6   Surface properties
The specific surface area of ENM provides one measure of confirming their assignment as a nanomaterial 
and provides an estimate of the surface area available for modification to incorporate functionality for spe-
cific applications. The specific surface area of solids is typically determined by measuring the amount of 
physically adsorbed gas according to the Brunauer, Emmett, and Teller (BET) method for interpreting gas 
adsorption isotherms [313, 314]. This method allows the determination of overall specific external and inter-
nal surface area of dispersed (e.g. dry nanomaterials) or porous solids; dry samples are degassed at elevated 
temperature (above 100 °C) before measuring adsorption of gas, typically nitrogen or argon. Although the 
BET method has been applied to some nanomaterials, there may be complications due to particle associa-
tion when samples are degassed at high temperatures, since the measured surface area of tightly associated 
particles is not equal to surface area of primary particles [291, 315]. It is also important to keep in mind that 
porous materials may have very high surface areas, without being nanomaterials, based on the size of indi-
vidual particles.
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6.6.1   Surface charge
Measurement of the zeta potential is one of the most common methods to determine the surface charge for 
NM. Zeta potential is defined as the difference between the electrical potential of the bulk liquid and that of 
the stationary layer of fluid attached to the dispersed particles (i.e. the slipping plane, which is the region of 
the liquid-solid interface where the liquid starts to slide relative to the surface under the influence of shear 
stress) [316]. Zeta potential is calculated using appropriate theoretical models from an experimentally meas-
ured parameter, such as the electrophoretic mobility [316]. A potential is applied across two electrodes in 
the sample cell and the movement of charged particles towards the oppositely charged electrode (cathode or 
anode) is measured as a function of the applied electric field. Particle mobility is typically measured by elec-
trophoretic light scattering, which measures mobility from the Doppler shifts in the frequency of scattered 
light from particles moving in the applied field [316–318].
Zeta potential is a useful parameter for assessing the stability of colloidal suspensions and studying 
adsorption on particles. A key consideration is that the calculated zeta potential is a function of both the par-
ticle and its surrounding solution and will therefore depend on the pH, temperature, particle concentration, 
ionic strength of the dispersing solution and the presence of polyvalent ions. As a general guideline, solu-
tions with negatively charged particles that have zeta potentials of −30 to −40 mV are considered moderately 
stable while values of −60 to −80 mV indicate very good stability [318].
6.6.2   Surface chemistry
The surface of nanomaterials is frequently functionalized to increase the stability of the material and prevent 
particle association, to improve its compatibility with other materials, or to add targeting moieties. The 
surface chemistry can dramatically change the properties of the nanomaterial, including its stability, surface 
charge, hydrophobicity/hydrophilicity, and, in some cases, size and morphology and association. Surface 
functional groups are also critical for controlling the behavior of the material when/if it is released to the 
environment, when it is used for biological purposes, or when it is incorporated in more complex materials. 
Despite the importance of surface functional groups, their quantitative analysis remains a considerable chal-
lenge. Although there are many possible methods that can be used, it is still relatively rare that more than one 
method is employed and even rarer that results are validated with multiple methods.
There are a large number of methods (see Table 3) that can be used to detect and quantify surface func-
tional groups on nanomaterials. The chosen method is dependent on the nanomaterial state (dry powders, 
colloidal suspensions or airborne particles) and the various methods have quite different sensitivities. Some 
methods, such as X-ray photoelectron spectroscopy (XPS), are typically applied to planar surfaces rather than 
nanomaterials, and others are more generally used for bulk materials. Two recent reviews have summarized 
the more commonly applied approaches [284, 300]. One recent report has provided an interesting compari-
son of XPS, solid-state NMR, and fluorescence for the quantification of surface carboxylic acids groups [319]. 
The comparison of methods with overlapping sensitivity ranges provided validation of the methods and is a 
useful first step towards reference materials for surface quantification.
6.7   Matrix-related restrictions
The methods described above are mostly appropriate for purified, pristine nanomaterial, but they are of 
limited or no use in complex matrices, such as soil, food, consumer goods, or body fluids. In some cases, this 
is because the nanomaterial is present in relatively low amounts and must be concentrated prior to analy-
sis. In other cases, the nanomaterial may be present in adequate quantities for detection and analysis but 
must be extracted from the matrix because other components of the sample are incompatible with the ana-
lytical method. The extraction and concentration methods needed are frequently unavailable or untested 
for specific combinations of nanomaterial and matrix. For biological samples, alternate approaches, such as 
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 labeling methods with antigens that can be detected with antibodies or with fluorophores, may be necessary 
to detect and quantify nanomaterials. In experimental settings, labelling with (radioactive) isotopes can also 
be employed. Although these approaches may allow for qualitative, or sometimes even quantitative, detec-
tion of the nanomaterial, it is challenging to obtain detailed information on the nanomaterial composition 
unless a relatively pure sample can be obtained free from the environmental or biological matrix.
7   Discussion and closing remarks
Engineered Nanomaterials have attracted significant attention due to their unique and potentially revolution-
ary properties. The number of applications in which ENM are expected to enable economic and technological 
advances is still growing very rapidly. Nanotechnology-based (or enabled) products are making their way to 
the marketplace, despite concerns about the safety of the synthetic nanomaterial or the products in which it 
is incorporated. In this first document, Engineered Nanomaterials and Human Health: Preparation Function-
alization and Analytical Characterization, we provided a brief overview of the terminology for nanomaterials, 
including the inconsistent use of the term “nano”, and then reviewed the generally accepted methodologies 
for the synthesis, functionalization, and characterization of some of the common types of ENM.
The wide variety of synthetic methods that have been developed now makes it possible to synthesize 
many types of ENM with specific and well-controlled shape, size, and dispersity [298]. However, the range of 
methods that have been extended to commercial or industrial scale production is considerably more limited 
and environmentally-friendly “green” synthetic methodologies are also lacking. There has been an exponen-
tial growth in the number of publications on the synthesis of new ENM with potentially novel properties and 
applications over the last several decades. Nevertheless, many studies fail to adequately characterize the new 
material or provide a comprehensive investigation of its biological behavior. Many studies also fail to docu-
ment whether the new material has significant advantages over existing materials. When ENM are explored 
as novel drug delivery systems, systematic attention should be paid to pharmacokinetic and pharmacody-
namic requirements in addition to loading yields and in vitro sustained release profiles, which are generally 
all that is provided in published investigations.
Functionalization is essential for most ENM, either to control particle stability and association or to 
impart biocompatibility or targeting to specific biological pathways. Reproducible control over the density 
and orientation of surface functional groups remains a significant challenge. Many functionalization strate-
gies are based on existing methods for surface modification or bioconjugation, but their application to ENM 
may be problematic due to the heterogeneity in particle size, surface composition, and the effects of particle 
curvature. Some strategies for surface modification give low yields and difficult-to-purify materials. Varia-
tion in surface properties, including defects and heterogeneity of surface coverage, can result in differences 
between materials with otherwise identical properties. Generally, covalent functionalization is preferable 
in order to avoid the loss of surface functionality, although in many cases the as-modified ENM will acquire 
additional surface coatings that vary with its environment and are often the dominant factor in controlling 
the biological activity. Control of orientation and distance between the NP and the attached ligand are critical 
in retaining biomolecule activity, but this has not been fully mastered.
Characterization of nanomaterials is mandatory for their reproducible commercial production and for all 
applications, including therapeutics, bio-diagnostics, and products that result in close contact between the 
nanomaterial and the human body (i.e. cosmetics, textiles, food). Analytical methods have evolved during 
the last two decades, with significant advances in sensitivity and ease of use. Despite these technological 
advances, as reviewed here, many methods are complex, expensive, and require skilled operators. They fre-
quently require detailed knowledge of the principles and, most importantly, the limitations of the method in 
order to correctly assess specific nanomaterial properties. Furthermore, the quantitative characterization of 
ENM in biologically-relevant environments, such as blood, cells, and tissues, remains a challenge. The lack of 
adequate characterization of nanomaterials in relevant environments (whether the human body, consumer 
products, or the environment) is recognized as a major limitation for the assessment of the effects of ENM 
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on human health. This problem must be addressed in order to develop realistic and enforceable regulatory 
requirements for the rapidly expanding nanotechnology field.
For human health applications, there are several challenges that will need to be addressed in the next 
decade. We can perhaps start with robust, environmentally friendly synthetic procedures that enable the 
preparation and purification of multifunctional nanoparticles on an industrial scale (i.e. to fulfil the vision 
of theranostics or multimodal therapies). Specific to antibody-coated nanomaterials, the future trends will 
likely be directed towards replacing the antibodies as the recognition elements by imprinting or engineer-
ing their binding epitopes directly to the NP surface (i.e. plastic antibodies). This would mitigate problems 
related to the loss of antibody activity due to denaturation or incorrect orientation when adsorbed on the 
surface and also long-term storage issues of antibody-conjugated NP. The concept of plastic antibodies along 
with carefully engineered NP surfaces (e.g. to protect the load from the environment, control the load release 
or minimize protein corona effects) could also reduce challenges associated with poor circulation half-life 
and premature clearing from the body and could even open new possibilities for the development of oral 
formulations for nanomedicine products. In this regard, it will be critical to measure and understand the 
changes in properties that occur when nanomedical products are introduced to the ‘hostile’ environment of 
the gastrointestinal tract and when (or if) they are metabolized in the liver. It will also be crucial to fully elu-
cidate the formation of a protein corona on nanoparticles in contact with biological systems.
Nanomaterials have been used systematically for decades, and also by chance for centuries, in various 
products of our daily life. Over the past few decades, we have learned how to manipulate materials on their 
atomic scale and how to produce totally new nanoscale materials with various novel features and properties. 
We have undoubtedly entered a new era with vast opportunities where nanotechnology and nanomaterials 
can be exploited in a huge number of possible applications. Companies and users often begin by considering 
only the business benefits or the advantages of a new material, but the past has demonstrated that materials 
and chemicals may have adverse effects for human health or the environment. As this is important for the 
sustainability and the safety of nanomaterials, we will address this topic extensively in Part II (Engineered 
Nanomaterials and Human Health: Applications and Nanotoxicology).
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